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ABSTRACT 
 
 Chlamydia species are responsible for over 1.2 million reports of bacterial sexually 
transmitted infections in the United States; a number that has been steadily increasing for the 
past decade. Worldwide, a cumulative 131 million new cases of Chlamydia trachomatis are 
estimated among individuals between ages 15-49. In most individuals, chlamydial infections are 
asymptomatic, resulting in long-term sequelae such as pelvic inflammatory disease, salpingitis 
and infertility. Along with genitourinary infections, Chlamydia is also the leading cause of 
blinding trachoma, affecting nearly 1.9 million people across 42 different countries. While 
current treatment with antibiotics remains successful in combating infections, evidence of 
persistent infections, acquisition of antibiotic resistances, and recurring exposure intensifies the 
necessity for enhanced prophylactic approaches, including the development of a vaccine. In 
order to develop these advances, species-specific targets, as well as mechanisms the bacterium 
uses to establish infection must be identified. My research focuses on two forward-genetic 
approaches to identifying these correlates of pathogenicity: homologous recombination and 
transposon mutagenesis.  
 Majority of information pertaining to Chlamydia’s pathogenicity in a mammalian host 
has been derived from the mouse-adapted species, Chlamydia muridarum. This species readily 
infects the vaginal canals of female mice and ascends to the upper genital tract— the primary site 
for causing disease in women. Conversely, the human-adapted strain, C. trachomatis, is 
incapable of ascension in the mouse model of infection and rapidly cleared. Even with the drastic 
differences in pathogenicity, C. muridarum and C. trachomatis share ~98% genome sequence 
identity, with most of the genetic differences occurring within the plasticity zone. In our efforts 
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to understand which genetic components are responsible for ascension, in vitro recombination 
between C. trachomatis and C. muridarum was completed, enriching for recombination around 
this plasticity zone. I used molecular approaches to characterize regions of crossover among the 
hybrid progeny, focusing on hybrids containing gyrA-2 from C. muridarum as an indicator for 
genetic exchange near the plasticity zone. Among the 35 hybrids assessed, only three showed 
integration of the large cytotoxins specific to C. muridarum: 4357, 4406, and 4537. These three 
recombinants integrated only two of the cytotoxins, TC0438 and TC0439; none of the samples 
showed integration of the third cytotoxin, TC0437. To assess whether TC0438 and TC0439 are 
responsible for C. muridarum’s ability to ascend to the UGT, I used the mouse vaginal model of 
infection with these hybrids. Three mice each were infected with the hybrids and uterine horns 
isolated for assessment of ascension.  Seven days post-infection, only one animal, infected with 
isolate 4406, showed detectable Chlamydia in the uterine horns. No other animals from any of 
the hybrids showed detectable organisms in the uterine horns, suggesting these two cytotoxins 
are not sufficient to cause a gain-of-function. The remaining 32 hybrids showed recombination at 
the same intergenic site between the C. trachomatis trpA and C muridarum TC0440. This region 
may indicate a recombination hotspot or chi site within Chlamydia or may highlight the selective 
pressure against C. trachomatis to harbor the cytotoxins. 
 Secondly, the development of a transposon system functional in Chlamydia permitted the 
analysis of single-gene disruptions and their roles in growth and development. I used Tn libraries 
generated in both C. trachomatis and C. muridarum to characterize in vitro and in vivo 
phenotypes. All 13 Tn mutants from C. trachomatis were single insertions while three of the 26 
C. muridarum mutants showed double inserts. One mutant from C. trachomatis, CT696::Tn, had 
a significant defect in growth in vitro resulting in lack of inclusion formation and aggregation of 
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RBs. In vivo, two mutants from each library, CT148::Tn and CT868::Tn from C. trachomatis, 
and TC0657::Tn and TC685::Tn from C. muridarum showed decreases in bacterial burden in the 
uterine horns of mice.  
 In addition, I performed in silico analysis of the Tn insert within the hypothetical protein 
CT339 from C. trachomatis. I ran BLAST analysis to identify the conserved competence motif 
then generated multiple sequence alignments and hydropathy predictions for structure. These 
indicated CT339 is a multi-pass transmembrane protein with structural homology to ComEC 
from Bacillus. I then used PCRs from three loci dispersed around the genomes of recombinant 
progeny to show that a disruption in CT339 prevents lateral gene transfer between C. 
trachomatis mutants and tetracycline-resistant C. suis R19. All recombinants with a C. suis 
OmpA seroreactivity incorporated the β-lactamase from CT339::Tn. No progeny showed 
tetracycline-resistance transfer into CT339::Tn. Experiments in which transformations were 
attempted with CT339::Tn mutants also showed no ability to uptake DNA, supporting the role of 
CT339 as both a structural and functional homolog of ComEC.  
Together, these two approaches provide the ability to assess large genetic loci and single-
gene roles in growth and infectivity of chlamydial species. Homologous recombination allows 
for generation of both gain- and loss-of-function mutants for the determination of genetic regions 
essential for pathogenesis; narrowing the genome for assessment of individual components 
within each region. Transposon mutagenesis offers the advantage of single-gene disruptions for 
direct genotype-phenotype correlations, as demonstrated by reduced bacterial burdens in 
mammalian infections and my discovery of CT339 as a homolog to ComEC.  
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Chapter I. General Introduction 
Chlamydial Impact on Public Health 
 
As early as the 1900s, scientists have been investigating the “parasite” responsible for 
infectious blindness plaguing nearly 53 countries—later identified as the obligate intracellular 
bacterium, Chlamydia (Knirsch 2007, Nunes and Gomes 2014, Taylor, Burton et al. 2014).  Over 
the next >100 years, research on numerous species, host adaptation, and basic biology would 
propel the organism to the forefront of microbial research and, most importantly, magnify the 
broad understanding of a radically atypical pathogen: one with a growing impact on public health 
and accumulating numbers of cases every year.  
As of 2009, the genus Chlamydia consisted of the 9 major species capable of infecting a 
range of hosts including: caviae (guinea pigs), felis (cats), pecorum and abortis (mammals), and 
the more biologically relevant species: suis, a swine-adapted strain exhibiting antibiotic 
resistance capable of transmission into human-specific strains; psittaci, a species infecting birds 
with potential zoonosis into humans; pneumonia, a human-adapted strain causing lung infections 
and pneumonia; muridarum, a rodent strain ideal for research in vivo due to strikingly similar 
acute genital infections and post-infection sequelae mimicking those observed in humans; and 
trachomatis, the most prevalent species infecting humans (Longbottom and Coulter 2003, De 
Clercq, Kalmar et al. 2013, Nunes and Gomes 2014).  
According to the Center for Disease Control and Prevention (CDC), over 1.5 million new 
cases of C. trachomatis infections occur annually, steadily increasing since 2000 (Figure 1.1). 
These numbers, however, do not include the other pathogenically relevant species such as C. 
pneumonia, which alone infects nearly 300,000 individuals in the United States annually; an  
	   2	  
	   3	  
  
Figure 1.1 Rate of reported C. trachomatis infections by sex, United States, 2000-2015. 
Figure acquired from the CDC 2015 Sexually Transmitted Disease Surveillance Report. It is 
noted that while data collection for Chlamydia infections began in 1984, it was not reportable 
in all 50 U.S. states and the District of Columbia until 2000. Increases in rates of reported 
cases may be due to both an increase in quality and awareness of testing capabilities and 
incidence of infection (U.S. Department of Health and Human Services). 
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approximation likely underestimated due to lack of reporting strategies and misdiagnoses 
(Cilloniz, Ewig et al. 2011).  
Among the most prevalent C. trachomatis species, three distinct subclasses (serogroups) 
are recognized based on differences within the major outer membrane protein, OmpA, and 
dictate which tissue type the organism is most likely to infect. The first serogroup consists of 
organisms predominantly infecting the ocular epithelium (serovars A through C), and are the 
causative agent of endemic trachoma. Recent reports from the World Health Organization 
suggest about 1.2 million people within 51 countries where Chlamydia-induced trachoma is 
endemic are irreversibly blind. It is estimated that upwards of 40 million others are suffering 
from active trachoma infections and are at high risk for developing permanent scarring and 
future blindness. (Knirsch 2007, Wright, Turner et al. 2008, Ramadhani, Derrick et al. 2016).  
Serovars D through K make up the second serogroup, infecting ano-urogenital tissue and 
collectively comprise the aforementioned 1.5 million sexually transmitted infection cases in the 
United States and estimated 90 million worldwide (Cochrane, Armitage et al. 2010, Tan and 
Bavoil 2012). These serovars are responsible for a number of reproduction-associated diseases 
including: proctitis and epididymitis in men, cervicitis and pelvic inflammatory disease in 
women, and urethritis and sterility in both sexes (Pellati, Mylonakis et al. 2008, Nunes and 
Gomes 2014).  
The final serogroup causes genital tract infections termed lymphogranuloma venereum 
(LGV), and are primarily manifested through rectal penetration (Kapoor 2008, O'Byrne, 
MacPherson et al. 2016). Infections with these serovars (L1 through L3) are generally divided 
into 3 stages due to their ability to cause invasive and systemic infections through macrophage 
dissemination (Tan and Bavoil 2012, Nunes and Gomes 2014). Stage 1 presents with localized 
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inflammation, small lesions, and discharge within a month after exposure. The second stage of 
infection may result in flu-like symptoms such as fever, chills, and malaise, due to the diffusion 
of Chlamydia to the lymph; genitally, the infection remains asymptomatic. More severe 
infections result in mucosal ulcers, lymphangitis and suppurative necrosis forming buboes 
surrounding the inguinal ligaments (Tan and Bavoil 2012, O'Byrne, MacPherson et al. 2016). 
Finally, the third stage of infection results in irreversible damage, sterility due to tissue scarring, 
and genital elephantiasis (Dal Conte, Mistrangelo et al. 2014, O'Byrne, MacPherson et al. 2016). 
Until recently, LGV infections in the developed world and western hemisphere were rare. Since 
2003, outbreaks have been identified in the Netherlands, U.S., U.K., and Australia, with the 
majority of cases occurring within men who have sex with men (Kapoor 2008, O'Byrne, 
MacPherson et al. 2016). 
Notwithstanding the high reports of infections, there is almost no evidence of antibiotic 
resistance in human-adapted Chlamydia species (Sandoz and Rockey 2010). C. suis, the swine-
adapted species, has shown acquisition of a genomic island containing tetracycline resistance 
genes; however, this is probably due to the high rate of antibiotic use as a means of growth 
promotion, driving the selection of rare organisms that have undergone this acquisition (Nunes 
and Gomes 2014). Indeed, clinical trials with two broad-spectrum antibiotics, azithromycin and 
tetracycline, resulted in over 95% of bacterial clearance and over 92% of long-term effectiveness 
(Lau and Qureshi 2002, Golden, Whittington et al. 2005, Geisler, Uniyal et al. 2015). Although 
treatment failures have been clinically reported (Batteiger, Tu et al. 2010, Geisler, Uniyal et al. 
2015), meta-analysis reports that the majority of lasting infections are the result of reinfections as 
opposed to antibiotic failure. Further, stressors such as beta-lactam antibiotics, as well as host 
immune responses, may induce a persistent state in many chlamydial species, including C. 
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trachomatis (Beatty, Morrison et al. 1994). This state results in metabolically inactive, “aberrant” 
forms of the organism, which are capable of evading treatment strategies. Upon removal of the 
stressor, either antibiotic clearance or the immune response diminishing, aberrant Chlamydia 
revert back to the active infectious cycle, resulting in chronic infections (Schoborg 2011). It is 
because of this phenotype, along with the majority of Chlamydia infections remaining 
asymptomatic that result in the ever accruing WHO and CDC disease reports and the necessity 
for more efficacious prophylactic approaches. To date, there is no vaccine available for any 
Chlamydia species, however, this is not due to lack of effort; simply, many facets of the 
organism’s biology, including correlates of immunity, remain poorly understood (Nunes and 
Gomes 2014, Rey-Ladino, Ross et al. 2014). 
 
Chlamydial Biology and Development 
 
 As mentioned above, the majority of complications in designing pathogen-specific 
antibiotics, inhibitory pharmaceuticals, or vaccines against chlamydial species are due to a 
general ignorance of the basic biology of the organism. Chlamydia species have a highly 
conserved ~1Mb genome and ~7.5kb plasmid, with as many as one-third of the coding regions 
resulting in proteins of unknown function, more commonly termed “hypothetical proteins” 
(Stephens, Kalman et al. 1998, Nunes, Borrego et al. 2013). Indeed, this lack of annotation has 
remained the crux of the biological setbacks for the organism and, given a complicated lifestyle 
yet reduced genome, there remains a number of cellular processes these unknowns may be 
playing a part in; with high probability for multifactorial roles and compensatory functions. 
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All species of Chlamydia are incapable of growth and survival outside of a host 
regardless of tissue tropism. They all maintain a complicated biphasic development cycle with 
two distinct forms known as the elementary body (EB) and reticulate bodies (RBs) 
(Abdelrahman and Belland 2005). The infectious cycle begins in which the metabolically 
inactive EBs bind to a host cell and initiate entry (Figure 1.2). A number of factors play a role in 
the attachment and entry of EBs into the host cells. This includes adhesion proteins such as the 
outer membrane proteins OmpA, OmcB and Hsp70, polymorphic membrane proteins (Pmps), 
and proteins involved in the type III secretion system (TTSS), such as the translocated actin 
recruiting phosphoprotein (TARP) (Abdelrahman and Belland 2005, Betts, Wolf et al. 2009). 
TARP functions to modulate host cell actin for the rearrangement and engulfment of C. 
trachomatis, yet it has been shown to be dispensable with EBs remaining capable of entry and 
infection when TARP is mutated or treated with inhibitors (Betts, Wolf et al. 2009, Parrett, 
Lenoci et al. 2016). Combined, these proteins aid in what was initially classified as ‘parasite-
specified phagocytosis’ in which EBs are shown to induce uptake within the host cell. However, 
many contradictory reports have demonstrated both the necessity and lack thereof for key 
receptors including, dynamin, clathrin, and lipid rafts (Dautry-Varsat, Subtil et al. 2005).  
 Once internalized, chlamydial EBs modify the parasitophorous vacuole, termed an 
inclusion, to evade the lysosomal-fusion pathway and manipulate the environment to promote 
growth and replication (Fields and Hackstadt 2002). As early as 2 hours post-infection, 
chlamydial EBs begin to undergo differentiation into the metabolically active, noninfectious RB 
form via unknown signals (Abdelrahman and Belland 2005, Tan and Bavoil 2012). Once 
differentiated, RBs localize to the edges of the inclusion for protein secretion across the 
membrane, including deubiquitinases (Le Negrate, Krieg et al. 2008), apoptosis inhibitors  
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Figure 1.2 Chlamydia developmental cycle. The infectious elementary body (EB) of 
Chlamydia first attaches and enters the host cell through a modified endocytosis.. After 
roughly 8 hrs, EBs convert to their metabolically active reticulate bodies(RBs) where they 
grow and divide. Around 24-48 hpi, RBs begin reverting back to EBs and finally around 72 
hours, Chlamydia either lyses the host cell or exits through a process known as extrusion, 
infecting neighboring cells. Under stressful conditions including nutrient starvation or the 
presence of antibiotics, Chlamydia enters a persistent state. Persistence results in large 
aberrant forms incapable of dividing or reverting back to EBs. Upon removal of the stressor, 
the aberrant forms revert back to RBs and continue on the normal developmental process. 
Figure modified from Kevin Hybiske. Insert—Green: MOMP staining of Chlamydia RBs, 
Blue: DAPI stain of host cell nucleus. 
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(Fan, Lu et al. 1998), and proteins involved in nutrient acquisition (McClarty 1994).  During this 
time, RBs are rapidly dividing through binary fission, generating over 1,000 organisms per 
infected cell (Tan and Bavoil 2012). Roughly 24-48 hours post-infection, RBs begin reversion 
back into EBs; this phase is considered asynchronous in that, while some RBs terminally 
differentiate back into the infectious form, many remain actively dividing to produce more RBs 
(Tan and Bavoil 2012). This hallmark of development illuminates another step in which cellular 
signals remain poorly understood. It has been speculated that RB dissociation from the 
membrane or TTSS removal may induce a reversion signal (Bavoil, Hsia et al. 2000). Finally, 
roughly 48 hours after initial infection, most RBs have reverted back into EBs and are released 
from the host cell using one of two methods: extrusion (the pinching off of the chlamydial 
inclusion enveloped in host-membrane), or lysis of the host cell (Hybiske and Stephens 2007, 
Zuck, Sherrid et al. 2016).  
As mentioned previously, in order to evade the host immune responses, as well as in the 
event of nutrient starvation or the presence of certain types of antibiotics, Chlamydia are capable 
of entering a persistent state (Figure 1.2). During this state, RBs expand, converting into an 
aberrant form (Schoborg 2011). A number of triggers for inducing these forms have been 
identified, including tryptophan starvation through host IFN-gamma induction, nutrient 
deprivation including amino acids and glucose, as well as the presence of penicillin, ofloxacin, or 
ciprofloxacin (Segreti, Kapell et al. 1992, Dreses-Werringloer, Padubrin et al. 2000). Upon 
removal of the antibiotics or reintroduction of necessary nutrients, Chlamydia reverts back to 
normal growth; however, studies have shown C. trachomatis is capable of resistance to 
azithromycin when previously exposed to penicillin antibiotics (Wyrick and Knight 2004). 
Tryptophan depletion due to IFN-gamma activity is the result of indoleamine 2,3-dioxygenase 
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(IDO) activation (Bonner, Byrne et al. 2014). IDO activation initiates the degradation of 
intracellular tryptophan levels, resulting in reduced levels of the amino acid available for 
chlamydial protein synthesis. Conversely, C. trachomatis possesses a tryptophan synthetase 
capable of converting indole produced by normal microflora in the genital tract into usable 
tryptophan (Xie, Bonner et al. 2002, Nelson, Virok et al. 2005, Bonner, Byrne et al. 2014). 
Through both the presence of aberrant forms, and overcoming host-tryptophan depletion, 
persistent infections occur producing sustained inflammation and tissue damage, resulting in the 
long-term sequelae alongside high frequencies of infection.  
 
Advances in Genetic Systems for Chlamydia 
 
 Due to the obligate intracellular nature of Chlamydia, along with the biphasic lifestyle, 
incorporation of foreign DNA (e.g. plasmid) has been problematic. EBs are capable of survival 
and infectivity extracellularly and as such, provide an anchor for exogenous DNA uptake into the 
host cell and inclusion; however EBs contain a rigid cell wall of tightly cross-linked proteins, 
prohibiting DNA from entering. On the other hand, the replicative RB form does not have the 
rigid cell wall, rendering it more susceptible to DNA acquisition. Unfortunately, RBs reside both 
within the host cell and inclusion, thus DNA is required to pass through four distinct membranes 
without degradation—host membrane, inclusion membrane, and RB inner and outer membranes 
(Bastidas and Valdivia 2016). To overcome this, external attachment or coupling of DNA to the 
EB surface is one method for integration of plasmid vectors but presents the challenges of 
environmental degradation, detachment, or disruption of essential EB/host interfaces..  
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 It was only within the past few decades that foreign DNA has been transiently introduced 
to Chlamydia; initially through electroporation and antibiotic selection using chloramphenicol 
resistance (Tam, Davis et al. 1994). It was not until nearly 14 years later that this system would 
be improved upon for the development of stable transformants in C. psittaci (Binet and Maurelli 
2009). It was found through these studies that exceedingly high concentrations of plasmid DNA 
was required, ranging from 5 to 20 µg, and resulted in reasonably low frequencies of 
transformation, identifiable only after several rounds of serial passages (Bastidas and Valdivia 
2016). In order to isolate clonal populations of these transformants, chlamydiologists developed 
modified plaque assays, adapted from those designed for viral particle counts (Matsumoto, Izutsu 
et al. 1998). However, clinical isolates, as well as environmental strains of Chlamydia, have 
shown to plaque poorly (Bastidas and Valdivia 2016). 
 Chemical transformation with shuttle plasmids designed for use in chlamydial spp. 
provided the next leap forward for introducing plasmid DNA into the organism, but, again, this 
represented a complicated and relatively ineffective method. Recombinant plasmids are often not 
taken up in the presence of a native plasmid and, in most cases of plasmid acquisition, native 
plasmids replicate more efficiently, resulting in deletion of the foreign plasmid and loss of gene 
transformation (Nordstrom and Austin 1989). Given that Chlamydia contain a native plasmid; it 
became imperative for transformation that plasmid-free isolates of C. trachomatis be developed. 
Wang et al. were incapable of curing LGV of its native plasmid and as a result, designed a 
shuttle vector system in which the chlamydial native plasmid was fused with their genes of 
interest, eliminating the complications associated with a recombinant plasmid (Wang, Kahane et 
al. 2011). This shuttle vector incorporated both chloramphenicol and penicillin resistance genes, 
providing a simple method for isolating transformed clones using selection with either antibiotic. 
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Standard laboratory protocols for transformation of bacteria calls for incubation with CaCl2 
followed by a “heat shock” to facilitate the entry of the plasmid DNA (Mandel and Higa 1970). 
It was found that, upon incubation of EBs with CaCl2 and McCoy cells (the standard fibroblast 
cell line used for growing Chlamydia), transformation was possible and heat shock was 
unnecessary. Recovery of bacteria was allowed to occur for at least one complete round of the 
developmental cycle before penicillin selection was implemented (Wang, Kahane et al. 2011). 
Stably transformed C. trachomatis was observed after three rounds of selection and 
transformation was verified via Southern Blotting. The development of a shuttle vector by Wang 
et al. marked an essential development in the field of chlamydial genetics. It allowed for the 
potential introduction of genes and use of genetic systems for the elucidation of previously 
unknown properties of chlamydial biology.  
In 2013, Wickstrum et al. designed a new shuttle vector utilizing a tetracycline-inducible 
system for the expression or repression of genes (Wickstrum, Sammons et al. 2013). In this 
system, the tetracycline repressor, TetR, remains tightly bound to operators found within the tetA 
promoter: tetO1 and tetO2. When bound, TetR strongly represses transcription of genes under the 
control of the tetA promoter. The presence of tetracycline or tetracycline derivatives then reduces 
the binding of the repressor to the operators, allowing for transcription of the downstream 
gene(s) of interest (Bertram and Hillen 2008). Fusing the tetracycline-inducible system to the 
native chlamydial plasmid, Wickstrum et al., were able to tightly control the expression of GFP 
under the control of tet-induction (Wickstrum, Sammons et al. 2013). Thus began the 
steeplechase to identify gene functions within Chlamydia.  
In addition to revolutionizing the capacity for exogenous DNA uptake, advances in 
chlamydial recombination have propelled the field into a new era of genetic discovery. Whole 
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genome sequencing of C. trachomatis showed that DNA recombination systems are “extensively 
represented” and therefore could be exploited for phenotype analyses (Stephens, Kalman et al. 
1998). DeMars et al. showed that antibiotic resistance acquisition via recombination occurred 
roughly 104 times more frequently than resistance due to spontaneous mutations and confirmed 
the genetic stability of in vitro recombinants (Demars, Weinfurter et al. 2007). Through 
recombination, a number of chimeras with the potential for innovative characteristics can be 
developed and the particular genetic loci associated with these phenotypes assessed. Indeed the 
observation of tetracycline resistance within C. suis and subsequent transfer to C. trachomatis in 
vitro shows the potential for cross-species recombination in order to identify genetic correlates, 
potentially hypothetical proteins, associated with host- and tissue-tropisms. Further, the transfer 
of antibiotic resistance genes into human-adapted Chlamydia strains reveals the foreboding 
public health obstacles looming on the horizon.  
 Modern techniques for genetic manipulation have also been developed for use in 
Chlamydia including targeted mutagenesis with the TargeTron system (Johnson and Fisher 
2013), chemical mutagenesis using ethyl methanesulfonate (Nguyen and Valdivia 2014), and 
gene deletions via allelic exchange (Mueller, Wolf et al. 2016). While each of these systems has 
benefits, many of them have disadvantages as well. TargeTron systems are dependent on 
knowing which gene to target and, with over 300 hypothetical gene products, it is difficult to 
know where to begin. Further, this system has demonstrated to be relatively inefficient in 
Chlamydia (Bastidas and Valdivia 2016). Chemical mutagenesis allows for spontaneous 
mutations to occur, overcoming the issue of having to select specific genetic targets for 
disruption. However, the numbers of mutations that occur eliminate the ability to associate a 
specific phenotype with a single gene disruption, requiring a follow-up application of targeted 
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genetics (Kari, Goheen et al. 2011). Allelic exchange combines both the groundbreaking ability 
to transform Chlamydia, with the ability to target specific endogenous genes for deletion. This 
system further allows for the introduction of new genes as well as the complementation of 
mutated or knockout genes, affording the ability to complete the molecular Koch’s postulates 
(Mueller, Wolf et al. 2016). Despite the robust advances made in genetic manipulation of 
Chlamydia, each method results in varying degrees of efficiency and brings variable levels of 
shortcomings. Future efforts to overcome these inadequacies are essential for the advancement of 
chlamydial biology, identification of gene products and functions, and discovery of innovative 




The process of homologous recombination is both well defined and highly utilized as a 
tool for gene mutation in pro- and eukaryotes (Packer and Liu 2015). While discoveries in 
microorganisms came later than those identified in higher-order organisms, it would become one 
of the most well-characterized pathways in bacteria (Michel and Leach 2012).  
The central protein within the recombination pathway and the first discovered in E. coli 
was RecA. With its crystallization in 1992, a number of domains essential for function, including 
two proposed DNA binding domains, were confirmed (Story, Weber et al. 1992, Michel and 
Leach 2012). These two domains are hypothesized to bind single-stranded DNA to double-
stranded DNA with complementary sequences, resulting in strand invasion and DNA synapsis 
reactions. Accessory proteins RecB, C and D initiate recombination through unwinding and 
“chewing back” of donor DNA. Almost all foreign DNA taken up by bacteria, either through 
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conjugation, horizontal gene transfer, or bacteriophage injection, undergoes this process 
(Lawrence and Retchless 2009). Upon recognition of a specific sequence known as the Chi site, 
RecA is recruited and strand invasion occurs, displacing the second strand from the resident, 
receiver DNA, forming what is called a D-loop. This D-loop can either be recognized as a 
replication fork, resulting in the generation of only one strand of recombinant DNA, or it can be 
nicked, resulting in a Holliday junction. Holliday junctions are further resolved using a DNA 
repair system RuvABC or RecG and result in two recombinant DNA strands (Michel and Leach 
2012). As mentioned previously, components from these systems have been extensively 
researched in E. coli for their roles in regulation and assistance in recombination; RecB and C 
proteins have been shown to have recombination deficient effects if mutagenized, however 
inactivation of RecD results in multimerization of plasmids and hyper-recombination events 
(McGrew and Knight 2003, Michel and Leach 2012).  
Within many bacteria, homologous recombination is an essential component for the 
evolution and “shuffling” of DNA—allowing for acquisition and/or removal of genes which may 
be either beneficial or damaging (Packer and Liu 2015). Recent studies in a number of organisms 
have shown the ability to identify novel virulence factors acquired through homologous 
recombination. Clinical isolates of Neisseria meningitides, for example, have highly dynamic 
genomes, classified by what is known as “sequence types.” Through genome analysis of two 
invasive strains within the same sequence type, ~35 “non-vertically” transmitted genes 
originating from different sequence types have been identified, contributing to the pathogenicity 
of the organism (Kong, Ma et al. 2013). Structural differences due to unequal recombination and 
duplication events within virulence factor cagA from Helicobacter pylori has led to emergence 
of geographically diverse elevations in virulence and chimeric C-terminal motifs (Furuta, Yahara 
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et al. 2011). Further, homologous recombination has been exploited experimentally for direct 
mutagenesis of organisms and analysis of gene roles in pathogenicity, as in Rickettsia 
prowazekii. Recombination resulted in replacement of WT phospholipase D with a partially 
deleted version, demonstrating the functionality of this gene product in bacterial survival 
(Driskell, Yu et al. 2009).  
In Chlamydia, homologous recombination was previously assumed improbable due to its 
intracellular nature and lack of infections with more than one strain (Harris, Clarke et al. 2012), 
however genome sequencing of C. trachomatis suggested otherwise. Variability within the outer 
membrane proteins (particularly ompA) and polymorphic membrane proteins (pmps) is observed, 
leading researchers to investigate whether key players in homologous recombination are present 
in Chlamydia, particularly the central player: RecA. Genome fragments from C. trachomatis 
were cloned and transformed into a RecA knockout E. coli strain and screened for a rescue in 
recombination. Coincidentally, the E. coli transformant exhibiting rescue consisted of a 
chlamydial fragment containing only one major open reading frame which, when compared to 
sequences of known RecA proteins, showed identities above 50% (Hintz, Ennis et al. 1995, 
Zhang, Fan et al. 1995).  
From these discoveries, the analyses of many chlamydial genomes identified numerous 
historical recombination events. Joseph et al. identified over 300 recombination events within the 
genomes from tissue isolates of C. suis, as well as DNA from both C. trachomatis and C. suis 
present within the C. muridarum genome, although they were not recombined among themselves 
(Joseph, Marti et al. 2016). Computationally, it is estimated that recombination affects short 
nucleotide segments, averaging ~350 bp with the majority occurring in serogroup two (serovars 
D through K), and the least amount of recombination occurring in LGV specific isolates (Joseph, 
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Didelot et al. 2012). One hypothesis for this is the environmental impacts placed on recombinant 
strains (Lawrence and Retchless 2009). Whereas serovars from group two may be exposed to 
each other quite frequently within the same environment through repeated infection and 
exposure, LGV-specific serotypes rarely co-culture in vivo with serovars outside this specific 
clade. Similarly, it is likely that regions surrounding niche-specific genes show lower rates of 
homologous recombination naturally; a theory assessed within later chapters of this dissertation.  
 
Horizontal Gene Transfer 
 
One very important mistake often made by geneticists involves differentiation between 
homologous recombination and horizontal gene transfer. Horizontal gene transfer typically refers 
to the method of DNA acquisition as well as potential origins, however the incorporation of new 
DNA into a recipient genome requires the ability of homologous recombination and thus, the two 
should be considered concurrently.   
Within Chlamydia, the first and most obvious example of horizontal gene transfer (HGT) 
is the presence of the genes encoding ATP/ADP transport proteins, allowing intracellular 
organisms to exchange ADP with host-manufactured ATP (Tjaden, Winkler et al. 1999). 
Evidence indicates that an ancient chlamydial ancestor, living as an endosymbiont, acquired 
these genes horizontally, potentially after a series of gene duplication events. Transport proteins 
such as these have historically only been utilized by plant and algal chloroplasts. In fact, 
Chlamydia genomes assessed for horizontal transfer have identified a greater number of genes 
gained from plants than those from metazoans and fungi (Koonin, Makarova et al. 2001). Recent 
follow-up studies have further identified similarly functional transport proteins in 
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Acanthamoeba, which is the recently classified C. trachomatis-related bacteria (Schmitz-Esser, 
Linka et al. 2004).  
Along with acquisition of single genes, the ability for entire operons or islands to transfer 
into new bacteria has been confirmed in a number of bacterial genomes, including Chlamydia. 
Koonin et al. identified operons containing Na+-transporting NADH:ubiquinone oxidoreductase 
and archaeal/vacuolar-type H+-ATPases horizontally transferred into C. trachomatis and C. 
pneumoniae (Koonin, Makarova et al. 2001) and the presence of a tetracycline resistance 
genomic island within C. suis isolates has been widely acknowledged (Dugan, Rockey et al. 
2004). 
One key process for HGT is the ability of bacteria to transform, or take up exogenous 
DNA. This process requires a number of proteins involved in DNA binding and processing and 
ultimately converges with the recombination pathway described above. Whereas some 
components of the system remain highly conserved between Gram-positive and Gram-negative 
bacteria, the presence of both an outer- and inner-membrane in Gram-negative bacteria 
necessitates additional protein constituents. In Gram-positive bacteria lacking an outer 
membrane, double-stranded “donor” DNA is bound by ComGC, a pilus extending beyond the 
peptidoglycan layer, and guided to the receptor protein ComEA. It is then degraded into single-
stranded DNA by the EndA nuclease (Dubnau 1999, Berge, Moscoso et al. 2002, Chen and 
Dubnau 2004, Johnston, Martin et al. 2014). This single-stranded DNA is then internalized 
through the ComEC transmembrane channel via the ComFA ATP-dependent translocase protein 
(Dubnau 1999). Once internalized, various processing proteins bind the single-stranded DNA, 
leading to the recruitment of RecA and progressing to homologous recombination (Johnston, 
Martin et al. 2014).  
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Gram-negative bacteria, on the other hand, utilize the type IV pilin/secretin channel for 
transport of DNA across the outer membrane (Figure 1.3). DNA is bound by the PilE subunits 
making up the pilus and is transported through the outer membrane via transmembrane secretin, 
PilQ (Chen and Dubnau 2004). Within the periplasm, the homolog of ComEA, ComE, binds 
DNA and delivers it through the inner membrane channel, ComA. While it is known that DNA 
must be processed into single-stranded DNA for recombination, the presence of a homolog to 
ComFA (the translocase protein in Gram-positives) has not been confirmed, nor has any nuclease 
similar to EndA been identified (Chen and Dubnau 2004). In C. trachomatis, while there is 
evidence for horizontal gene transfer, none of the bacterial uptake proteins described above have 
been annotated. 
 
Transposon (Tn) Mutagenesis 
 
Arguably one of the most powerful tools for the study of pathogenesis has been the 
optimization of transposon mutagenesis. The ability to design any gene insert as the transposon 
itself, coupled to it’s applicability to a vast number of organisms, makes it one of the most 
groundbreaking tools available for genome manipulations. Since their discovery over fifty years 
ago in Zea mays by Barbara McClintock, “jumping genes” have provided a number of options 
for researcher. These include the ability to assess phenotypes from disrupted genes, the potential 





Figure 1.3 Scheme of Bacterial DNA uptake machineries. A) In Gram-positive bacteria, 
ComGC subunits make up the transformation pilus, which captures double-stranded DNA 
(dsDNA) and brings it to the DNA receptor ComEA and transmembrane pore ComEC. The 
EndA nuclease breaks the dsDNA into single-stranded DNA, which is then brought into the 
cell through the ATP-dependent translocase ComFA. ComGB and ComGA stabilize the 
ComGC pilus. B) In Gram-negative bacteria, the transformation pilus is composed of PilE 
subunits and dsDNA is internalized through the outer membrane via PilQ. The DNA receptor 
homolog ComE guides DNA in through the ComEC transmembrane pore homolog, ComA. 
The EndA nuclease homolog remains unknown. PilG and PilF stabilize the PilE pilus within 
the inner membrane. PG=Peptidoglycan.  
 
Adapted by permission from Macmillan Publishers Ltd: [Nature Reviews Microbiology] 
(Johnston, C., B. Martin, G. Fichant, P. Polard and J.-P. Claverys (2014). "Bacterial 
transformation: distribution, shared mechanisms and divergent control." Nat Rev Micro 12(3): 
181-196), copyright (2014). 
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sequencing—the utilization of whole-genome sequencing combined with transposon 
mutagenesis to identify genotype/phenotype correlations on a genome-wide scale.  
 Two major classes of transposable elements (TE) have been augmented for use in 
research. Class I elements require the reverse-transcription from an RNA intermediate (Finnegan 
1992, Hamer, DeZwaan et al. 2001). This class of TE has been widely used in mutagenesis of 
eukaryotes and is the main class of TE found within viruses, containing two subclasses, I.1 and 
I.2 (Finnegan 1992, Gebert and Rosenkranz 2015). Both subclasses contain open reading frames 
similar to the retroviral gag and pol genes, in that, they code long polyproteins. Class I.1 
elements also contain long terminal repeats, whereas Class I.2 elements contain A-rich sequences 
at the 3’ tails (Finnegan 1992, Konnyu, Sadiq et al. 2013). 
The mechanisms for how Class I TEs integrate into the genomes of respective organisms 
also mimic that of retroviral infections; transcription of the TE depends on one long terminal 
repeat for initiation, typically at the 5’ end, and contains open reading frames for the reverse 
transcriptase. Upon transcription completion, promoter sequences for the reverse transcriptase 
allow for translation of the enzyme that then reverse transcribes the remaining RNA construct 
into double-stranded DNA (Deininger and Batzer 2002). For Class I.1 TE, this double stranded 
DNA is then incorporated at specific sequences within the genome using nicks—a method 
similar to Class II TE (see below). For Class I.2 TE, the mechanism for DNA integration remains 
poorly understood. Contradictory research results show that gene rearrangement and truncations 
may occur resulting in point mutations often associated with this class of TEs and is highly 
dependent on cellular enzymes for nicks, ligation, and other processes. Regardless of subclass, 
Class I TEs are always replicative, meaning that the original RNA transcript is never removed. 
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Because of this, accumulation of these insertions may occur over many generations (Deininger 
and Batzer 2002). 
 Class II TEs are undoubtedly the more widely used class for bacteria due to the ease of 
application. These TEs transpose directly from DNA into DNA using their own internal 
transposase, removing the necessity for reverse transcription and genetic modification within the 
cell (Hamer, DeZwaan et al. 2001). These mechanisms require only magnesium, GTP and the 
respective insertion site (sequence) within the genome of the receiving organism and result in a 
non-replicative insertion. These TEs also appear less frequently within human and plant genomes 
(Finnegan 1992, Ammar, Izsvak et al. 2012). One noteworthy example of Class II TEs within the 
human genome are the RAG1 and RAG2 genes required for VDJ-joining in antibody 
development. It is estimated that these proteins have existed among jawed vertebrates for nearly 
500 million years, transposed within the human genome, conferring an evolutionary advantage 
and thus remaining conserved (Kapitonov and Jurka 2005).  
  Given the ease of employment, Class II TEs have become essential tools for molecular 
biologists. The two most prevalent systems for DNA transposons include the PiggyBac (PB) 
system and Sleeping Beauty (SB). The newly designed PB system functions by the standard “cut 
and paste” mechanism common within Class II TEs, but only inserts at TTAA regions in a 
genome (Di Matteo, Matrai et al. 2012). Compared with viral vectors for genetic insertions, PB 
is more convenient to generate and results in more precise insertion due its lack of the requisite 
DNA synthesis for sealing gaps (Yusa 2015, Zhao, Jiang et al. 2016). In contrast to other Tn 
systems, PB has a number of advantages: anywhere from 9 to 14 kb-long fragments can be used, 
typically integrating as single-copy transgenes, with higher efficiencies of transposition, offering 
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precise excision and restoration of wild type sequences. They can be readily located using 
traditional molecular methods (Zhao, Jiang et al. 2016).  
Notwithstanding the benefits of the PB system, two major disadvantages remain: 1) PB 
generally requires that the transgene and transposase be present on two separate plasmids to 
account for their increased sizes, requiring dual-plasmid uptake, and 2) PB was derived from 
insects, therefore codon usage within bacteria and mammalian cell lines remains an issue, 
resulting in a decrease in expression. While codon-optimization and mutating inverted repeat 
sequences has resulted in dramatic increases in both excision and integration within a genome, 
the issue of dual plasmid uptake remains (Di Matteo, Matrai et al. 2012). An attempt to combine 
the transposon and transposase on one vector, resulted in irregular integration, weak tranposase 
expression, and variable levels of GFP transgene expression (Chakraborty, Ji et al. 2014). These 
initial attempts at modification, however, highlight the deficiencies within the system and pave 
the way for improvements. 
Sleeping beauty is so named due to its “awakening” or resurrection from the Tc1/mariner 
element found in fish genomes—these TEs were originally thought to be nonfunctional in 
vertebrates due to their accumulation of mutations. They have since been engineered for 
functionality; in fact, this system represents the first-ever ancient gene to be actively 
reconstructed (Ivics and Izsvak 2015). Using highly conserved consensus regions within the 
Tc1/mariner family, Sleeping Beauty was engineered, establishing the overall structure (the 
DNA-binding domain and the catalytic domain) now found in all mariner superfamily 
transposases (Plasterk, Izsvak et al. 1999). Similarly, the mechanism for transposition is also 
retained in the superfamily, broken into 4 major steps: 1) binding of the transposase to the 
inverted repeats, 2) pairing of the homologous IRs, 3) excision of the donor site, and 4) 
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integration into the target site. One of the major benefits to the SB system is its integration site 
selection—almost exclusively between AT nucleotides (Ivics and Izsvak 2015). The opportunity 
for randomized insertion across a genome provides significant benefits scientifically, however, it 
has been shown that palindromic AT regions with potential for hydrogen bonding generates 
genome “hotspots,” or preferential regions of insertion. Not surprisingly, this structural 
predilection is conserved among other Tc1/mariner transposon systems.  
Similar to the Sleeping Beauty system, another mariner transposon called Himar1 has 
been shown to have stable integration of transgenes and, upon mutation, has shown an increased 
frequency of transposition as compared to WT Himar1 (Lampe, Akerley et al. 1999, Keravala, 
Liu et al. 2006). This “C9 hyperactive transposase” has been extensively applied for analysis of 
pathogenesis in a number of organisms including intracellular bacteria (Maier, Casey et al. 2007, 
Beare, Howe et al. 2009, Cheng, Nair et al. 2013). The C9 hyperactive transposase also inserts 
randomly between AT nucleotides, however, the propensity for long palindromic sequences and 
easily hydrogen-bonded regions, as is observed in SB, have not been assessed.  
Regardless of system, transposon mutagenesis as a whole has provided inestimable 
insight into the pathogenesis of a number of bacteria. Genome-wide, random insertions have 
identified genes responsible for abscess formation from Streptococcus intermedius (Hasegawa, 
Sekizuka et al. 2017), hyper-invasiveness of Campylobacter jejuni (Javed, Grant et al. 2010), and 
biofilm formation in uropathogenic E. coli (Hadjifrangiskou, Gu et al. 2012). To date, however, 
the development of a transposon mutagenesis system functional in Chlamydia has not been 
described. Thus, the research described herein defines a functional Tn system within C. 
trachomatis and proceeds to characterize a small library of Tn mutants. 
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The central theme of this research focuses on identifying genomic components 
responsible for varying degrees of pathogenicity. For each area described above, a unique 
application resulted in appreciable information including identifying multi-gene loci responsible 
for specific phenotypes and potential gain-of-function mutants (horizontal gene transfer and 
homologous recombination). Equally, this also includes single gene disruptions through 
transposon mutagenesis for loss-of-function phenotypic analysis. Combined, this research has 
identified 1) a disinclination for C. trachomatis to acquire cytotoxin genes when allowed to 
recombine with C. muridarum in vitro, 2) mutants of FAD-dependent monooxygenase and 
ChlaDub1 from C. trachomatis, and MACPF, glgB and glucose-6-phosphate isomerase from C. 
muridarum show a decrease in recoverable organisms in vivo using a mouse-infection model and 
3) a critical role for CT339 of C. trachomatis in lateral gene transfer. Chapter II describes my 
characterization of C. trachomatis and C. muridarum recombinant progeny generated by Bob 
Suchland at the University of Washington. I used PCR and sequence analysis to determine 
regions of genetic crossover and a comprehensive evaluation of genes gained and lost through 
recombination. With the help of Nancy Schwarting, I then used the mouse vaginal model of 
infection to determine if hybrids containing two of the C. muridarum cytotoxins were capable of 
ascension to the upper genital tract. I used droplet digital PCR on both ovaries and uterine horns 
to determine bacterial burdens in each organ.  
Chapters III and IV describe the use of transposon mutagenesis systems developed by 
Jason Wickstrum and Dr. Scott Hefty to generate single-gene disruptions in C. trachomatis and 
C. muridarum. C. trachomatis Tn mutants were generated by Jason, Michael Barta and Gregory 
Peterson. Scott LaBrie did microscopic analysis, and Greg Peterson performed flanking PCRs 
and southern blots to identify single inserts in C. trachomatis mutations. C. muridarum Tn 
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mutants were generated by Yibing Wang and Kevin Hybiske at the University of Washington. I 
ran droplet digital PCR to identify multiple insertions in C. muridarum Tn mutants. I propagated 
mutants from both libraries and assessed bacterial burdens in vivo with the assistance of Nancy 
Schwarting. Chapter IV focuses of the role of CT339 in lateral gene transfer. I performed the in 
silico analysis and generated the multiple sequence alignments, hydropathy plots and topology 
predictions. Bob Suchland generated recombinant clones between CT339::Tn, CT383/4::Tn 
(IGR) and C. suis R19. I performed PCRs on loci dispersed across the genomes to identify 
parental backbone and directionality of genetic transfer. Chapters III and IV were combined and 
modified to include only the C. trachomatis Tn characterizations and submitted to mBio. This 





Bob Suchland at the University of Washington generated all recombinant clones used in this 
research. Brian Brunelle at the USDA, , performed whole genome sequencing of recombinant 
hybrids and generated contigs for sequence analysis. Jason Wickstrum and P. Scott Hefty 
generated plasmids used for transposon mutagenesis. C. trachomatis libraries of mutants were 
generated by Jason Wickstrum, Michael Barta, and Gregory Peterson. Gregory Peterson also 
performed flanking PCR, Southern blotting, and ddPCR of  C. trachomatis Tn mutants. C. 
muridarum Tn mutants were generated by Yibing Wang and Kevin Hybiske at the University of 
Washington. Scott LaBrie, with assistance from the Microscopy and Analytical Imaging core at 
the University of Kansas, performed all microscopy and generation of Figures 3.6 and 3.7. 












Chapter II.  
Lateral Gene Transfer Between C. trachomatis and C. muridarum Allows for 




Chlamydial infections are the most commonly reported bacterial STI and the leading cause of 
preventable blindness worldwide. Notwithstanding this impact on public health, chlamydial 
pathogenesis remains poorly understood. One feature of Chlamydia biology is the variable host 
specificity and infectability despite highly similar genomic content between strains. An essential 
property of infection differential between murine (C. muridarum) and human (C. trachomatis) 
species is the ability to ascend to the upper genital tract using a mouse infection model: C. 
trachomatis is unable to ascend, whereas C. muridarum readily ascends leading to pathology. To 
investigate possible genetic factors associated with these phenotypes, we employed the ability of 
Chlamydia to undergo lateral genetic exchange between species. Genetic hybrids of C. 
muridarum and C. trachomatis were isolated and evaluated for their ability to ascend. Genomes 
of hybrids were then compared to parental strains to identify regions of genetic variance. Among 
the 35 isolated hybrids, 32 showed recombination within the same region, flanking but no 
incorporating the cytotoxins. Three isolates recombined two cytotoxins. Upon investigations in 
vivo, it was found these two cytotoxins were insufficient for ascension. Further investigations 
utilizing genetic hybrids may identify correlates of host- and disease-specificity and elucidate 






 Genetic recombination is a central node for increasing diversity and promoting survival 
in all living things. Among eukaryotes, naturally occurring recombination events during meiosis 
and mitosis occur due to overlapping of sister chromatids during metaphase alignment (Marston 
and Amon 2004). Within bacteria, genetic recombination typically stems from horizontal gene 
transfer between microbes in which foreign, donor DNA become integrated into a recipient cell. 
This integration results in two different avenues of recombination: plasmid or chromosome 
transformation (Kidane, Ayora et al. 2012). In both, regions of sequence homology between 
processed donor ssDNA and recipient DNA allows for transient molecular interactions, the result 
of which leads to incorporation of the donor DNA. With the current advances in whole genome 
sequencing, it has been found that extensive homologous recombination occurs between 
widespread varieties of species and may serve as an essential contributor to the origination and 
virulence of many pathogens (Spratt, Hanage et al. 2001, Lawrence and Retchless 2009, Kong, 
Ma et al. 2013).  
 Less than a decade ago, it was discovered that Chlamydia is also capable of homologous 
recombination. Chlamydia is the leading bacterial sexually transmitted infection worldwide and 
the leading cause of non-heritable blindness worldwide. At present, mechanisms behind the 
complicated developmental cycle and pathogenesis, including the ability to ascend to the upper 
genital tract—the primary site for causing disease, remain poorly understood. Similarly, it has 
been observed that a fraction of individuals previously treated for C. trachomatis infections 
remain positive for infection at follow-up exams—potentially due to the organism’s ability to 
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evade host immune responses and the presence of latent infections (Demars, Weinfurter et al. 
2007). This evasion may, in part, be due to the organism’s capability to undergo homologous 
recombination. Veritably, clinical isolates from urogenital tracts showed intergenic 
recombination among outer membrane protein-encoding genes ompA and pmpC; two proteins 
vital for immune recognition and clearance of the organism (Demars, Weinfurter et al. 2007). It 
is well known that chlamydial infections begin with an elementary body (EB) becoming 
endocytosed into a host cell and rapidly hijacking and altering the endocytic vacuole (inclusion) 
for its own use, such as evasion of lysosomal fusion (Fields and Hackstadt 2002). At high levels 
of infection in vitro, it has been observed that multiple EBs may be endocytosed, resulting in 
many inclusions present within one host cell (Bernkopf, Mashiah et al. 1962, Blyth and Taverne 
1972, Ridderhof and Barnes 1989). Remarkably, it has been found that these numerous 
inclusions are capable of fusing with one another, resulting in one large inclusion containing all 
the endocytosed EBs (Ridderhof and Barnes 1989), while concurrently preventing lysosomal 
fusion. This ability allows for interaction of multiple EBs, potentially from different strains or 
serovars, facilitating the observed instances of homologous recombination (Hayes, Yearsley et 
al. 1994). 
 In Chlamydia, intentional co-infections in vitro using strains containing distinct antibiotic 
resistances and subsequently placing these organisms under dual-antibiotic selection has resulted 
in the isolation of recombinant progeny containing both resistance markers. Customarily, this 
application has been applied to C. trachomatis for the generation of novel, selectable isolates for 
experimental use (Demars, Weinfurter et al. 2007), however, Jeffrey et al. showed homologous 
recombination may also be applied to identify genotype-phenotype correlations (Jeffrey, 
Suchland et al. 2013). These studies showed recombination among the polymorphic membrane 
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proteins (Pmps) from C. trachomatis clinical isolates is associated with rectal tissue tropism and 
resultant in vitro generated C. trachomatis recombinants altered the organism’s ability to attach 
to host cells and generate secondary inclusions in serovars F, J and L2 (Jeffrey, Suchland et al. 
2010, Jeffrey, Suchland et al. 2013). 
The study reported here, however, is the first to evaluate the ability for interspecies 
homologous recombination to occur between C. trachomatis and C. muridarum. These two 
species contain ~98% sequence identity, yet show drastically dissimilar pathogenesis in the 
mouse model of infection (Thomson, Holden et al. 2008, Stephens, Myers et al. 2009) C. 
muridarum is capable of ascending to the upper genital tract where it causes pathology following 
vaginal infection, as is observed with infections in women. C. trachomatis, on the other hand, is 
readily cleared following vaginal infections in mice, rarely ascending to the upper genital tract 
(UGT). Notwithstanding high genomic similarity between C. trachomatis and C. muridarum, 
diversity in pathogenicity may be the result of a specific region with substantial sequence 
variation, known as the plasticity zone (loci between dsbB and ycrF genes; (Figure 2.1 (Rajaram, 
Giebel et al. 2015)). Positioned roughly 12 kb to the right of the PZ lies the DNA gyrase subunit 
A (gyrA in C. trachomatis; gyrA-2 in C. muridarum), in which C. muridarum is naturally 
ofloxacin resistant. This naturally occurring resistance is absent from C. trachomatis, however, 
spontaneous mutations have been detected in vitro leading to similar resistance (Suchland, 
Bourillon et al. 2005). Within the PZ itself, major differences include the presence of three large 
putative cytotoxins (~10 kb each) and a guaBA operon in the C. muridarum genome, while C. 
trachomatis lacks the cytotoxins and encodes a tryptophan synthesis operon in place of the 
guaBA (Rajaram, Giebel et al. 2015). Studies focused on this plasticity zone have revealed 





Figure 2.1 Schematic of C. muridarum and C. trachomatis Plasticity Zones (PZ). Map 
showing the genetic difference between plasticity zones. A) C. muridarum plasticity zone 
between TC0430 and TC0448. The three large cytotoxins are highlighted in dark red. B) 
Plasticity zone of C. trachomatis between CTL0407 and dsbB. Fragments of cytotoxin 
TC0439 are shown in striped dark red. The tryptophan synthesis operon is shown in dark blue. 
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C. muridarum and single mutations in two of these cytotoxins (tc0437 and tc0439, respectively) 
resulted in reduced toxicity in vitro, with decreased bacterial burden at early time-points of 
mammalian infection (Rajaram, Giebel et al. 2015). Given these initial observations, it is 
hypothesized that this region, particularly the cytotoxins within, are responsible for the 
substantial differences in mammalian pathogenesis. Unfortunately, the generation of double- and 
triple-mutants amongst the cytotoxins has proven to be a challenge. Similarly, the cloning and 
purification of recombinant cytotoxins using E. coli has been unsuccessful (Newman 2015).  
In order to overcome these obstacles, homologous recombination was exploited. The 
generation of progeny consisting of a primarily C. trachomatis background, yet containing 
regions of the C. muridarum plasticity zone (i.e. one or more cytotoxins), provides an 
opportunity for discovery of a novel gain-of-function: C. trachomatis isolates capable of 
ascending to the UGT using a mouse vaginal model of infection. Relatedly, the introduction of 
C. trachomatis plasticity zone genes may result in loss of function recombinants: C. muridarum 
isolates incapable of ascension. Collectively, this research not only reports the first observations 
of recombination occurring between C. trachomatis and C. muridarum, but it also allows for 
identification of genetic regions interchangeable between them, narrowing the gap in 









Methods and Materials 
 
Chlamydial strains and selection for recombinants. All experiments with tetracycline-resistant 
Chlamydia described in this work were reviewed and approved by the National Institutes of 
Health Recombinant DNA Advisory Committee (University of Washington). Tetracycline and 
rifampacin dual-resistant Chlamydia trachomatis L2/434/Bu and ofloxacin resistant C. 
muridarum (Nigg) were generated as previously described (Figure 2.2 (Suchland, Sandoz et al. 
2009)) and kindly provided by Robert J. Suchland at the University of Washington. Briefly, shell 
vials containing McCoy cells (ATCC CRL-1969) were infected with C. trachomatis and allowed 
to grow for ~8 hrs at which point C. muridarum was added at a combined MOI of 1. Cultures 
were allowed to infect 24-48 hours. Upon detection of growth, cells from individual shell vials 
were detached using -80°C/37°C freeze-thaw and split into 96 individual shell vials. 
Recombinants were selected using triple antibiotic selection with tetracycline, rifampicin, and 
ofloxacin and allowed to propagate until visible inclusions were detected. Vials containing 
detectable inclusions were then diluted 1:10 and split into 96-well plates and allowed to continue 
propagation under antibiotic selection. Per plate, roughly 1-5 wells showed chlamydial growth 
(Figure 2.3). These wells were then isolated and cloned via limiting dilution. C. trachomatis L2-
specific monoclonal antibodies for IncA and OmpA were used to identify parental background 
flanking the plasticity zone. 
 
PCR determination of recombination regions. In order to identify genetic regions of 
recombination near the plasticity zone, PCR was performed using either C. trachomatis or C. 
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muridarum species-specific primers (Table 2.1). DNA was isolated from samples by centrifuging 
aliquots, removing supernatant and boiling pellets in water at 95°C for 10mins. Standard Taq 
polymerase was used with the following PCR conditions: 95°C for 1 minutes; 35 cycles of 95°C 
for 30 seconds, 54°C for 30 seconds, 72°C for 1 minute; 72°C for 5minues, 4°C hold. PCR 
product was analyzed on 1.5% agarose gels ran at 90 volts. Amplicons were sent for sequencing 
using ACGT, Inc. (Germantown, MD). 
 
Whole Genome Sequencing of Recombinants. In order to identify precise regions of genetic 
overlap, whole genome sequencing and contig assembly was kindly performed by Brian Brunelle 
(National Animal Disease Center, ARS, USDA, Ames, Iowa). Contigs were sent as FASTA files 
and BLASTed to identify the precise region of sequence overlap from each parent, C. 
trachomatis or C. muridarum. Table of genes lost, gained and replaced was generated for sample 
3220 using the BLOSUM62 matrix with an E-value <1e-6 to identify orthologous genes 
(Pearson 2013). 
  
Immunofluorescence microscopy. In order to determine infective titers for in vivo studies, IFM 
was performed as previously described (Osaka, Hills et al. 2012). Using 8-well ibiTreat µ-Slides 
(Ibidi, Martinsried, Germany), L929 cells were grown to confluency and infected with respective 
recombinant progeny. Cells were fixed with 100% methanol ~24 hpi, and washed three times 
with PBS.  Slides were stained using either the MicroTrack C. trachomatis culture confirmation 
test (Syva Co., Palo Alto, CA) or Virostat Chlamydia MONOTOPE Fluorescein Conjugated 
IgG1 LPS, diluted in PBS at room temperature in the dark or overnight at 4°C overnight. 20µl of 




Table 2.1: Primers used to determine recombination regions 
C. trachomatis x C. muridarum PCR (5’-3’) 




C. trachomatis  trpA GCTATCTAACCGCTGGTGATG 347 
TCTTCCAGCACCTTTATCACAC 
C. trachomatis dsbG 
GGATTAATTTCTCTTCCGGAATGCGTAGG 
362 GGTGCATAAGGATCCCCTATCGTAGG 
C. trachomatis gyrA/ 
C.muridarum gyrA-2 
TCGATGGATCCAAAATTCCCTTGACC 318 CCTCTTCAAGATTTTTAGGGACGATG 
C. muridarum TC0437 
TTTGATCGGAGGGCATTTAG 
643 AAGTCCCTCGAAGCAACTCA 
C. muridarum TC0438 
CTGACGAGAGCACTTGGTGT 
618 TTCCCTTTCTTGTCCCGCTC 
C. muridarum TC0439 
GTCAGCGCTTTAGGATTGCG 
612 GGTCCTCAGCTCCAAAACGA 
C. muridarum TC0440 
CTTACCCATCCCGTCATTCTT 
405 CTCTTCTTCTCGAGGACGTTTC 




allowed to stain RT in the dark. Stain was then removed, and the cells washed with PBS. A final 
overlay of  0.1M tris-glycerol was added and cells were imaged using an Olympus IX81 inverted 
epifluorescence microscope. IFU/µL was calculated for each recombinant and used as the pre-
infection titers. 
 
In vivo mouse infections. Female C57BL/6 mice 6-8 weeks old were purchased from Jackson 
Laboratories and housed in accordance with the University of Kansas Institutional Care and Use 
Committee requirements. 2.5mg Medroxyprogesteronacetat (Depo-Provera, Pfizer, NY) was 
used to treat mice subcutaneously upon arrival (day -7). Unthawed aliquots of either WT C. 
trachomatis, WT C. muridarum or recombinant clones were diluted to a final dose of 1x104 IFU 
in sucrose-phosphate glutamic-acid (SPG) buffer and kept on ice until use. Using 
nasopharyngeal swabs (Puritan,	   Guilford, Maine), vaginal vaults were swabbed and the infective 
dose was administered using sterile tips in conjunction with a P10 pipette. Tips were inserted 
until reaching the cervix of the animals, slightly withdrawn and inoculated. Animals were held 
briefly with the tip still inserted to ensure no dose was secreted or pulled out upon removal of the 
pipette tip. L929 monolayers were infected with serial dilutions of each dose and stained 24 hpi 
as described above for calculations of post-inoculation titers. Data are shown as scatter dot plots 
with mean and standard deviation for 3 mice. Statistics were calculated using GraphPad Prism 
version 7.0b (La Jolla, CA). 
 
ddPCR assessment of Chlamydia infection in vivo. Seven days post-infection, mice were 
humanely euthanized and the genital tracts were collected in SPG. Using a rotor/stator 
homogenizer (Biospec, Bartlesville, OK), organs were homogenized and 100uL aliquots were 
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frozen at -20°C until use. Remaining stocks of homogenized tissues were stored at -80°C. Using 
the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA), DNA was isolated from the 100µL 
aliquots and used for droplet digital PCR. Table 2.1 lists sequences for primers and probes for 
Chlamydia rpoB and mouse rpp3. ddPCR Supermix for Probes was used to set up PCR reactions 
and Oil-for-Probes droplet emersions were generated using the droplet generator cassette (Bio-
rad, California). The PCR conditions are as follows: 95°C for 10 minutes, 40 cycles of 94°C for 
30 seconds and 60°C for 1 minute, and 98°C for 10 mins followed by cooling to 4°C.  The 
QX200 droplet reader (Bio-Rad, California) was used to calculate fluorescent reads. Data was 
analyzed using the QuantaSoft Software (Bio-rad, California) and reported as a ratio of 
Chlamydia DNA to host DNA (rpoB/rpp30, copies/µL). Box and whisker scatter plots were 
generated in GraphPad Prism 7 and recoverable organisms were compared using unpaired, 
















Generation of C. muridarum and C. trachomatis recombinant progeny.  
C. trachomatis and C. muridarum exhibit high sequence similarity (~98%), with majority 
of genetic variation occurring within the plasticity zone (PZ, Figure 2.1). It was thus proposed 
that these large differences were responsible for the radical dissimilarity observed during 
mammalian infections using a mouse model (Stephens, Myers et al. 2009). Given that this PZ 
encompasses 20-50kb due to the presence or absence of cytotoxins, the prospect of directed 
genetic disruptions remains unmanageable and, previous communications have demonstrated 
introducing C. muridarum PZ components into C. trachomatis are unsuccessful, particularly the 
introduction of the three large cytotoxins from C. muridarum (K. Fields, personal 
communication, CBRS, 2017). In order to investigate how this region may be playing a role in 
the differentiation in pathogenesis, the natural ability of Chlamydia to undergo lateral gene 
transfer was exploited. Both species were used to co-infect monolayers at high MOIs, likely 
resulting in multiple inclusions per cell. The fusion of these inclusions allows for direct 
interaction of C. trachomatis and C. muridarum and the exchange of genetic material, resulting 
in hybrid progeny containing loci from each species.  
 Recombinant progeny were isolated through triple antibiotic selection using tetracycline, 
rifampicin and ofloxacin (Figure 2.2). As can be seen from the diagram, it is postulated that 
ofloxacin resistance came from the naturally resistant C. muridarum gyrA mutation, whereas 
tetracycline and rifampicin resistance (due to mutations in rpoB) originated from C. trachomatis. 
These respective markers were selected not only because of their availability but also their 
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location around the genome. Through this selection, progeny containing a primarily C. 
trachomatis backbone would be enriched for, with recombination occurring near the plasticity 
zone to include components from C. muridarum. Given that the distance between the tetracycline 
marker and the rifampicin marker is rather large, it cannot be ruled out that multiple regions of 
recombination may have occurred between them. In order to evaluate this, immunofluorescence 
microscopy was performed. C. trachomatis-specific antibodies reactive to the major outer 
membrane protein, OmpA, were used due to the gene’s positioning between the tet and rif 
resistance markers (Figure 2.2). C. trachomatis-specific antibodies reactive to IncA were also 
used due to the gene’s proximity to the plasticity zone; IncA lies to the right of the Tet Island, 
just left of both the plasticity zone and gyrA, providing an “endpoint” for recombination in this 
region—i.e. components from C. muridarum integrated between IncA and the rif-resistance 
marker. Through these selective approaches, isolated progeny should contain a primarily C. 
trachomatis backbone (counter-clockwise: IncA, tet-resistance, OmpA and rif-resistance), with 
regions of C. muridarum near the plasticity zone, between rif-resistance and IncA, including 
gyrA, Figure 2.2). 
 
Recombination occurs at a very low frequency.  
Previous in vitro experiments in which two different Chlamydia species, C. suis and C. 
trachomatis, were permitted to recombine resulted in low recombination frequencies. Therefore 
it was expected that C. muridarum and C. trachomatis experiments would show higher 
frequencies of recombination due to more genetic similarity, but still low overall rates (Suchland, 
Sandoz et al. 2009). Due to the faster growth rates of C. muridarum, cultures were initially 





Figure 2.2 Antibiotic resistances of parental and recombinant progeny. The generation of 
recombinant progeny was done using co-cultures of tetracycline and rifampicin resistant C. 
trachomatis LGV (blue) and ofloxacin resistant C. muridarum Nigg (red). After incubation 
without selection for 48 hours, cultures were treated with all three antibiotics and monitored 
for progeny growth. Survival indicated isolates contained all three antibiotic markers. The 
location of the C. muridarum ofloxacin resistant marker shows recombination occurred near 
or within the plasticity zone (PLZ). Given the low frequency of recombination events, it is 
expected the distance between the tetracycline and rifampicin resistance markers is C. 
trachomatis LGV origin, resulting in a predominantly LGV genome. 
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contained about 8.6x106 IFU of C. trachomatis and C. muridarum combined (Figure 2.3) which 
was then treated with antibiotics and diluted into 96-well plates.  In spite the high initial titers, 
each experiment yielded an average of ~1 well containing recombinant, triple-antibiotic resistant 
progeny (range 0-7). 
 
Spontaneous mutation in gyrA results in ofloxacin resistant C. trachomatis. 
As a result of various recombination experiments, 65 clones have been harvested and 
initially characterized via PCR to determine whether ofloxacin resistance is due to the presence 
of C. muridarum gyrA acquired through recombination or a spontaneous mutation in C. 
trachomatis gyrA. Considering that all harvested isolates are resistant to ofloxacin, it is expected 
gyrA from each would sequence to that of C. muridarum. In order to streamline experiments, 
primers were designed at conserved regions within gyrA to bind both C. muridarum and C. 
trachomatis. Internal sequence, however, differed enough such that sequencing of amplicons 
allowed for discrimination between each species. Unexpectedly, numerous samples sequenced to 
C. trachomatis gyrA, leading to the investigation of possible spontaneous mutations resulting in 
ofloxacin resistance. Indeed, the presence of a TàA mutation and resulting conversion of serine 
to arginine at position 83 was identified (Figure 2.4). It has been previously shown that similar 
mutations confer resistance to fluoroquinolones in E. coli and Staphylococcus aureus, albeit 
substituting leucine rather than arginine (Sreedharan, Oram et al. 1990, Bagel, Hüllen et al. 1999, 
Barnard and Maxwell 2001); therefore this comparable mutation is likely having the same effect.  






X 100 shell vials 
No Selection 
Mix 1:1 Ratio 
C. trachomatis LGV 
C. muridarum  
At MOI~1  




Dilute 1:10  
Split into 96 well plates 




Figure 2.3 Schematic showing recombination protocol. For the generation of recombinant 
progeny, the following scheme was utilized. Equal ratios of antibiotic resistant C. trachomatis 
LGV and C. muridarum Nigg were used to infect monolayers in shell vials at an MOI of 1 
without selection. After 24-48 hrs, individual shell vials were split into 96 new vials 
containing host cells, and treated with triple antibiotic selection. Upon observation of 
recombinant progeny growth, individual vials were diluted and split into 96-well plates and 
monitored for growth. As indicated, one plate typically generates 1-5 wells of progeny, 
highlighting the extremely low frequency of recombination. Isolates from the 96-well plates 






















Figure 2.4 Identification of gyrA spontaneous mutation. Genome sequencing of gyrA pcr product revealed sequences 
from several clones aligning to C. trachomatis gyrA. A) Analysis of sequence demonstrated a point mutation at nucleotide 
202 resulting in T!A conversion (blue) changing codon AGT ! AGA. Quality values for each base are graphically 
represented below the chromatogram (gray). B) Analysis of this change in reference to the protein sequence resulted in a 





Figure 2.4 Identification of gyrA spontaneous mutation. Genome sequencing of gyrA PCR 
product revealed sequences from several clones aligning to C. trachomatis gyrA. A) Analysis 
of sequence demonstrated a point mutation at nucleotide 202 resulting in TàA conversion 
(blue) changing codon AGT à AGA. Quality values for each base are graphically 
represented below the chromatogram (gray). B) Analysis of this change in reference to the 
protein sequence resulted in a Serine to Arginine conversion at amino acid 83 (highlighted in 
yellow). 
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Identification of recombination regions.  
While the subset of clones containing the spontaneous mutation may still be chimeric, 
efforts to characterize the library were shifted to focus on those samples definitively 
recombinant, as determined by the presence of C. muridarum gyrA-2 sequence. In order to 
identify if any part of the C. trachomatis plasticity zone was present, genes specific to the 
tryptophan synthesis operon were assessed. Primers for trpA were designed and PCR on the 
remaining 35 isolates was performed (Table 2.2). For nearly every sample a band was observed, 
proposing that genome regions from incA to trpA are of C. trachomatis origin. Primers further 
downstream of trpA were designed to amplify dsbG, however, no bands amplified for any 
samples, signifying a cross over region between trpA and dsbG in which the genome becomes C. 
muridarum. 
As the central hypothesis emphasizes the role of cytotoxins in pathogenic diversity 
between C. muridarum and C. trachomatis, PCRs determining whether chimeric isolates contain 
the cytotoxins were assayed. Primers amplifying fragments of TC0437, TC0438, and TC0439 
were used on each of the gyrA-2 positive clones. It was found that among the 35 samples, only 3 
amplified bands for TC0438 and TC0439 (Figure 2.5). All three samples showed bands at similar 
sizes to the parental C. muridarum control and as expected, no bands are present in the C. 
trachomatis parental samples. None of the isolates amplified TC0437. These three samples were 
then propagated and used for analyses in vivo.  
The remaining 32 samples were assessed for recombination beyond the absent cytotoxins. 
Interestingly, of the 27 samples tested, 23 showed bands amplifying TC0440, suggesting the 
genome spanning from TC0440 to gyrA-2 (TC0461) originated from C. muridarum. As 
mentioned above, the majority of samples did not amplify for TC0495, suggesting a  
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61 Yes No Yes 
88 Yes No Yes 
89 Yes No Yes 
105 Yes No Yes 
107 Yes No Yes 
112 Yes No Yes 
126 Yes No Yes 
136 Yes No Yes 
149 N.D. No N.D. 
155 Yes No No 
408 Yes No Yes 
501 Yes No Yes 
522 Yes No Yes 
672 Yes No Yes 
871 Yes No Yes 
940 Yes No Yes 
986 Yes No N.D. 
1299 N.D. No N.D. 
1521 Yes No No 
1790 Yes No No 
1970 N.D. No N.D. 
2043 Yes No Yes 
2562 N.D. No N.D. 
2697 N.D. No N.D. 
2845 N.D. No N.D. 
3106 Yes No Yes 
3220 Yes No Yes 
3401 No No N.D. 
3710 Yes No Yes 
4375 Yes TC0438, TC0439 Yes 
4406 Yes TC0438, TC0439 Yes 
4537 Yes TC0438, TC0439 Yes 
4665 Yes No Yes 
5053 Yes No No 
5254 Yes No Yes 





























Figure 2.5 Isolates 4357, 4406, and 4537 contain two cytotoxins from C. muridarum. 
PCRs using primers specific to the three cytotoxins from C. muridarum, TC0437, 8 and 9 
were used. Ct=Wild type C. trachomatis parent, Cm=Wild type C. muridarum parent. All 
three cytotoxins amplify ~600bp (table 2.1). C. trachomatis does not amplify any cytotoxins 
while bands are present for all three in the C. muridarum samples. Corresponding bands at the 
same size are observed for all three samples when amplified using TC0438 and 9 primers, 
signifying these samples contain two of the three cytotoxins. 
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recombination occurred between TC0461 and TC0495. This region encompasses over 30 genes 
and greater than 50kb of sequence. It was determined at this point that genome sequencing 
should be implemented to determine precise regions of recombination. Three samples, 3220, 
3106, and 2043 were randomly selected, grown to high titer, and DNA isolated for sequencing. 
Samples were sent to Dr. Brian Brunelle at the USDA who kindly provided the whole genome 
sequencing. Contigs were generated and returned for analysis of genomes. Upon BLASTing 
sequences, it was found that for all three, recombination occurred within an intergenic span 
between trpA and TC0440 (Figure 2.6). The second recombination region, though, differed 
greatly between them. The first and second samples, 3220 and 3106, had recombination points 
within coding regions of genes from each species. Sample 3220 had recombination in CTL0444: 
a C. trachomatis inclusion membrane protein and TC0464: a hypothetical protein from C. 
muridarum. Table 2.3 shows the composition of genes between each recombinant region in 
isolate 3220. Whereas only two C. trachomatis genes were lost (CTL0425/6), six novel genes 
from C. muridarum were incorporated, including three genes with no discernable C. trachomatis 
orthologs. The majority of genes were annotated to functionally replace those from C. 
trachomatis, likely retaining their respective roles in growth and infectivity (Table 2.3). 
 Sample 3106 showed recombination within the DNA gyrase subunit B from both 
species, resulting in similar genes gained/lost as 3220, except the C. muridarum thymidylate 
kinase (tmk) and partial TC0464 (Figure 2.6B) The third and final sample, 2043, had the largest 
portion of C. muridarum sequence with the second region of recombination occurring 
intergenically between TC0470 and oppA3. Whereas this intergenic overlap and the combination 
of gyrB2 from each species in sample 3106 likely did not disrupt any gene functions, the mosiac 
outcome between CTL0444 and TC0464 from sample 3220 may have drastic effects within the 
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cell. Future studies wherein more comprehensive analysis into whether this chimeric gene 
produces a functional protein and/or if possible domains are retained between fragments of 
CTL0444 and TC0464, or whether this fusion results in severe downstream effects will be 
advantageous for the investigation of roles these genes may have. 
 
Recombinant clones do not ascend to the upper genital tract during mammalian infection.  
As mentioned above, C. muridarum strains are capable of ascending to the upper genital tracts 
(UGT) of mice after a low-dose vaginal infection. C. trachomatis strains are not capable of this, 
instead requiring much higher doses and resulting in more rapid clearance of infection. It was 
postulated that cytotoxins present only in C. muridarum are responsible for this difference—thus 
the existence of these genes within a C. trachomatis genetic background may result in hybrids 
capable of ascension. Through techniques directing recombination near or within the plasticity 
zones of each species, three C. trachomatis hybrids were obtained encoding cytotoxins TC0438 
and TC0439. In vivo experiments were done to determine whether these cytotoxins confer the 
ability to ascend to the UGT of mice after vaginal infection with low titers. Parental C. 
muridarum and C. trachomatis strains used for the generation of these hybrids were included as 
positive and negative controls for ascension, respectively. As these experiments were simple 
“yes vs. no” experiments in terms of ascension, only three animals were used per group. One 
hybrid clone showing recombination within the plasticity zone that did not include acquisition of 
the cytotoxins was also included (sample 2043). Whole genome sequencing data was obtained 
for this isolate; therefore altered phenotypes due to procurement of new genes via recombination, 






Figure 2.6 Schematic of recombination regions based on whole genome sequencing. 
Whole genome sequencing was done on three hybrid samples. Based on BLAST analysis, 
regions of homology and likely crossover for recombination were identified (gray). All three 
samples showed the same crossover event at trpA and TC0440. A) Sample 3220 showed 
homologous sequence within CTL0444 and TC0464. B) Sample 3106 showed homology 
within gyrB2, resulting in a chimeric gene. C) Sample 2043 demonstrated the largest span of 
C. muridarum sequence with recombination occurring at an intergenic region between 





Table 2.3.  Summary of genome alterations following C. muridarum and C. trachomatis lateral gene transfer 
Unique C. trachomatis genes lost 
 
Unique C. muridarum genes acquired 
Gene Function Gene Function 
CTL0425 Hypothetical, pseudogene TC0441 Hypothetical 
CTL0426 Hypothetical guaA GMP synthase 




  TC0445 Hypothetical 
C. muridarum genes acquired potentially replacing C. trachomatis deleted ortholog 
Gene Function Deleted ortholog in C. trachomatisa 
TC0446 Peptide ABC transporter CTL0427 (oppA2) 
TC0448 dsbB CTL0428 (dsbB) 
TC0449 dsbG CTL0429 (dsbG) 
TC0450 Hypothetical CTL0430 
TC0451 Hypothetical CTL0431 
TC0452 ABC transporter CTL0432 
TC0453 Hypothetical CTL0433 
ksdB 3-deoxy-manno-octulosonate cytidylyltransferase CTL0434 (kdsB) 
pyrG pyrG CTL0435 (pyrG) 
TC0456 Holliday junction resolvase CTL0436 
zwf Glucose-6-phosphate 1-dehydrogenase CTL0437 (zwf) 
TC0458 Glucosamine-6-phosphate isomerase CTL0438 (devB) 
TC0459 DNA polymerase III, tau subunit CTL0439 (dnaX) 
tmk Thymidylate kinase CTL0440 (tmk) 
gyrA-2 gyrA CTL0441 (gyrA) 
gyrB-2 gyrB CTL0442 (gyrB) 
TC0463 Hypothetical CTL0443 
TC0464 Inclusions membrane protein CTL0444 
C. muridarum genes acquired with existing orthologs in C. trachomatis 
Gene Function Existing orthologs in C. trachomatisa 
TC0440 Phospholipase D family protein CTL0339, CTL0411, CTL0413, CTL0414a 
TC0444 Hypothetical CTL0418, CTL0419 
TC0447 Phospholipase D family protein CTL0339, CTL0411, CTL0413, CTL0414a 
 
aBLOSUM62 matrix E-value <1e-6 
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Cervix and uterine horns were harvested seven days post-infection and bacterial burden 
within each organ was assessed (Figure 2.7). All animals infected with parental C. muridarum 
had high levels of detectable bacteria in the uterine horns as expected, while C. trachomatis-
infected animals had levels over four-log lower (Figure 2.7A). One animal infected with 
recombinant clone 4406 showed bacterial levels over 10-2 in the uterine horns, but the other two 
animals from that group showed levels below WT C. trachomatis-infected animals, bringing the 
group average down. Overall, the recombinant and C. trachomatis-infected animals showed 
significantly lower levels of bacteria in the uterine horns as compared to C. muridarum (p<0.01). 
Considering that organisms were deposited directly into the vagina (abutting the opening 
of the cervix), these tissues provide evidence for the ability to establish and maintain infection, 
even if bacteria are unable to ascend. As shown in Figure 2.7B, mean values for C. muridarum 
and isolate 4357 were the highest at roughly 1, while cervix values for animals infected with 
4406 fall one-log below these. C. trachomatis and 4537-infected animals were detected at 
roughly two-log below C. muridarum at ~10-2. A relative level of variation was observed among 
these groups spanning nearly 3-logs, which may be indicative of animals clearing infection. 
Unexpectedly, animals infected with recombinant isolate 2043 were the lowest and showed no 
real variation in detection. This clone does not encode any of the cytotoxins but has the largest 
region of C. muridarum sequence as determined by whole genome sequencing (Figure 2.6C). It 
could be that C. muridarum sequence replaced C. trachomatis genes imperative for establishing 
infection (genes between trpA and oppA3). To determine this, future studies utilizing timepoints 
to identify when bacterial clearance occurs should be implemented. Similarly, evaluations with 

















































































Figure 2.7 Vaginal infections with recombinant clones. Three recombinant clones PCR-
amplified two cytotoxins from C. muridarum: TC0438 and TC0439. To assess whether these 
confer the ability to ascend, vaginal infections with low doses (1x104 IFU) were used. Seven 
days post-infection, genital tracts were isolated and ddPCR was used to determine bacterial 
burdens. A) Presence of detectable Chlamydia in Uterine horns indicates the ability of 
organisms to ascend from the vaginal vault to the upper genital tract. B) Cervix samples 
verify infectivity and identify possible clearance of infection. Data are shown as individual 





Within nearly all bacterial species, homologous recombination has been shown to 
contribute to the vast genetic diversity and virulence of a number of pathogens (Lawrence and 
Retchless 2009) including C. trachomatis. Previous studies both in vitro and using clinical 
isolates have identified evidence of recombination occurring in outer membrane proteins 
(Gomes, Bruno et al. 2004), and the horizontal transfer of antibiotic resistance markers between 
species (Suchland, Sandoz et al. 2009). Within the past decade, the use of recombination as a 
means to associate genetic loci with certain phenotypes has increased dramatically, leading to the 
identification of specific genes contributing to chlamydial tissue tropisms (Jeffrey, Suchland et 
al. 2010). Although studies have predominantly focused on genetic exchange within serovars, the 
potential for transfer between species provides an enhanced capacity for phenotypic assessments. 
It has been shown that tetracycline resistance genes from C. suis are capable of recombining into 
the C. trachomatis genome; yet, it appears that few other genes are freely exchanged, potentially 
due to a lack of genetic compatibility (Suchland, Sandoz et al. 2009). Moreover, the 
investigations of whether recombination occurs between C. trachomatis and other species such 
as C. muridarum, C. pneumoniae, or C. psittaci have not previously been implemented.  
This study marks the first report of intentional homologous recombination between C. 
trachomatis and C. muridarum. In spite of highly similar genetic content, these species show 
dramatically contrasting pathogenesis in a mouse model of infection. The plasticity zone (PZ), a 
locus with the greatest genetic diversity, is then inferred to be responsible for these disparities in 
pathogenesis—more specifically, three large putative cytotoxins present in C. muridarum that 
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are absent from C. trachomatis (Figure 2.1). To assess whether these genes, and/or genes within 
this locus are playing a role in infectivity, directed recombination using antibiotic resistance 
markers flanking the PZ was exploited. C. muridarum is naturally ofloxacin resistance in gyrA-2, 
the gene positioned left-flanking the PZ, while C. trachomatis strains used in this study are both 
tetracycline and rifampicin resistant. (Figure 2.2). Co-culturing both species and selecting with 
all three antibiotics allows for isolation of recombinant progeny likely comprising a 
predominantly C. trachomatis genome, possessing C. muridarum genes from regions near gyrA-
2. C. trachomatis genetic composition was further enriched through the selection of progeny 
staining positively with C. trachomatis IncA and OmpA antibodies. Taken together, these 
features should result in hybrids containing C. muridarum genes spanning incA to rpoB, the gene 
responsible for rifampicin resistance in C. trachomatis (Figure 2.2). Perhaps not surprisingly, it 
was found that the generation of these recombinants was highly inefficient. Initial titers from co-
cultures were ~107 IFU/vial at which point all three antibiotics were added (Figure 2.3) however 
splitting these cultures among 96-well plates resulted in a range of 0-7 wells containing triple-
resistant isolates (Table 2.2). Further, it was determined that among those isolates selected for 
subsequent characterization, nearly half of the clones contain a spontaneous mutation in gyrA 
from C. trachomatis, rendering cultures resistant to ofloxacin. This antibiotic resistance marker 
is the only indicator of C. muridarum genes; therefore it is likely most, if not all, of these 
spontaneously resistant clones are not hybrids but rather wholly C. trachomatis. 
Due to the high rate of spontaneous gyrA mutation, emphasis was placed on 
characterizing those mutants with C. muridarum gyrA-2 sequence. The principal hypothesis 
highlights the C. muridarum cytotoxins, which are lacking in C. trachomatis, as the basis for 
differences in pathogenesis; so the presence of these genes was assessed. Shockingly, <10% of 
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the isolates tested amplified cytotoxin sequence. Moreover, all three of the cytotoxins are not 
present in any sample. Instead only two of the three, TC0438 and TC0439, amplified. As shown 
in Figure 2.1, the C. trachomatis genome contains fragments purportedly from TC0439, 
annotated as pseudogenes. Consideration was taken in designing primers such that these 
fragments would not amplify. In silico PCR was used to verify primers will not amplify anything 
from C. trachomatis, confirming the presence of C. muridarum-derived TC0439 (San Millán, 
Martínez-Ballesteros et al. 2013) .  
These three isolates encoding TC0438 and TC0439 were then used to vaginally infect 
mice and assessed for the ability to ascend to the UGT. Only one animal infected with isolate 
4406 showed detectable Chlamydia levels in the uterine horns approaching those observed with 
C. muridarum, however, other animals in this group did not show similar burdens (Figure 2.7). It 
cannot be disregarded that this highly infected animal may be the result of technical error during 
administration of the infective dose. Applying the dose too closely to the cervical opening may 
unintentionally promote deliverance into the UGT. The presence of a similar infection profile in 
the corresponding cervical data indicates that, indeed, this is likely due to inaccuracy during 
dosing. Nearly all groups show a gradual reduction in detectable organisms from the cervix. This 
may be indicative of infection clearance with all animals reaching peak infection levels between 
10-2 and 1 at earlier timepoints. Overall, future studies using larger samples sizes as well as 
varying time of harvest will identify whether the observed data in 4406 is an artifact of 
administration or a true gain-of-function, and whether 2043 clears from mammals rapidly or if 
this was also a dosing issue.  
Perhaps the most noteworthy outcome from analyzing recombinant clones was the 
observation that transfer of cytotoxins from C. muridarum into a C. trachomatis genetic 
	  66	  
background is highly unfavorable; potentially due to the presence of a recombination “hotspot” 
occurring upstream of TC0440. It may also be the result of more complicated outcomes, such as 
toxicity to C. trachomatis, incompatibility with cellular machinery, or the requirement of other 
genetic factors that may not have transferred with these respective loci. Similarly interesting is 
the number of samples found to possibly recombine at the same region of homology. It was 
found using whole genome sequencing that the first recombination crossover occurred 
intergenically between trpA and TC0440 for three of the isolates: 3220, 3106, and 2043 (Figure 
2.6). Nearly all-remaining samples amplified sequence for both trpA and TC0440, suggesting the 
potential for crossover at this region as well. Collaborative efforts with Dr. Kevin Hybiske’s lab 
at the University of Washington revealed a number of recombinant clones from their library also 
show recombination at this exact sequence (personal communication, 2017).  It is undetermined 
whether this region may be functioning as a chlamydial chi site since previous publications have 
analyzed recombination in C. trachomatis exclusively (Jeffrey, Suchland et al. 2013). It may be 
that this inter-species approach identified novel recombination “hotspots” within either C. 
trachomatis or C. muridarum. Another explanation for these observations may be directly related 
to the incapacity of C. trachomatis to incorporate the cytotoxins. As previously mentioned, 
efforts to clone them have been unsuccessful, theoretically due to their large ~10 kb size. This 
and other research may indicate size is not necessarily the limiting factor; rather, incorporating 
all three cytotoxins into C. trachomatis may be lethal. Within the isolates that did amplify 
cytotoxins, only two of the three were recombined, leading to the queries: 1) if it’s a viable 
possibility, why don’t more isolates show recombination incorporating these two cytotoxins and 
2) why can’t TC0437 transfer into C. trachomatis? It may simply be that sequence similarity 
flanking TC0440 provides a more compatible region of homology. With the recent development 
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of both transformation and allelic exchange for use in Chlamydia, hypothesis such as this one 
can be readily examined.  
This research describes the first evidence that homologous recombination may occur 
between C. trachomatis and C. muridarum. We also show that the incorporation of genes 
downstream of TC0439 into C. trachomatis does not confer the ability to ascend in a mouse 
vaginal infection model; instead, it may result in a decreased ability to establish infection 
entirely, likely due to the loss of genes critical for growth and survival. It is anticipated that the 
ability to ascend is dependent on many genetic factors. Through recombination, large genome 
regions may be exchanged incorporating entire operons or gene clusters essential for 
pathogenesis. Recombination between these two species provides an opportunity to develop both 
C. trachomatis gain-of-function mutants capable of ascending to the UGT of mice, or loss-of-
function C. muridarum isolates incapable of ascension. This development narrows the genome to 
easily discernible, phenotype-associated loci from which individualized genetic analysis can be 
performed. Subsequent identification of explicit factors essential to infectivity allows for 
generation of novel therapeutics targeting pathogen-specific markers. Conclusively, the 
innovation of this technique provides a fundamental approach for determining genetic correlates 






Single Insertion and Disruption Using a Novel Transposon Mutagenesis 




Transposon mutagenesis is a widely applied and powerful genetic tool for the discovery 
of genes associated with selected phenotypes, including infection and pathogenesis. To apply this 
genetic tool for investigations in Chlamydia, a novel Himar1 transposon mutagenesis system was 
developed. This system was used to generate two small libraries of transposon mutants: one for 
C. trachomatis and C. muridarum. The libraries include transposons inserted into genes encoding 
putative deubiquitinase (CT868/CTL0247; cdu1), membrane proteins (TC0411 and TC0189), 
competence associated (CT339/CTL0593; comEC) proteins as well as nine different proteins of 
unknown function. The majority of Tn insertion clones exhibited tissue culture growth 
characteristics similar to parental clones supporting that these gene products are not essential for 
in vitro growth. To determine if these insertional mutations have an effect during mammalian 
growth and infectivity, female mice were infected either transcervically (C. trachomatis mutants) 
or intravaginally (C. muridarum mutants). Four Tn mutants from C. trachomatis infected 
animals have shown significant decreases in recoverable organisms from the upper genital tract 
five days post-infection, whereas two from C. muridarum infected animals have shown similar 
decreases nine days post-infection. To date, this transposon mutagenesis system represents a 
novel technique for random, single-insertion disruptions in Chlamydia spp. and provides an 





Transposon (Tn) mutagenesis is among the more effective strategies for discovering 
specific genetic components that are associated with a given phenotype. This genetic tool has 
been successfully applied for a better understanding of many basic biological processes as well 
as the discovery of gene products associated with host infection and pathogenesis in diverse 
Gram-negative and Gram-positive bacteria as well as Mycobacterium (Lampe, Akerley et al. 
1999). For instance, evaluation of comprehensive transposon mutant libraries have led to the 
disruption, and ultimately the classification of genes responsible for M. tuberculosis growth 
within macrophages (Camacho, Ensergueix et al. 1999), tissue penetration and dissemination in 
Pseudomonas aeruginosa (Jacobs, Alwood et al. 2003, Liberati, Urbach et al. 2006, Alarcon, 
Evans et al. 2009) and in vivo bacteremia in Streptococcus pneumoniae (Hava and Camilli 2002). 
Through transposon-based discovery of virulence factors, many excellent candidates for 
directing novel antibiotics and therapeutic efforts have been identified.  
Over a decade of optimizing naturally occurring transposon systems such as Sleeping 
Beauty and Tc1/mariner has resulted in a repertoire of successful genetic insertion systems 
(Hamer, DeZwaan et al. 2001). One of the more widely applied transposons is the hyperactive 
form of the Himar1 mariner system (Lampe, Akerley et al. 1999). This variant has resulted in 
robust transposon efficiencies and has revolutionized the study of genotype-phenotype 
correlation (Keravala, Liu et al. 2006). The Himar1 system has many benefits that have allowed 
application in phylogenetically diverse bacteria (Finnegan 1992, Lampe, Churchill et al. 1996, 
Beare, Howe et al. 2009, Clark, Lackey et al. 2011, Cheng, Nair et al. 2013, Newton, Kohler et 
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al. 2014, Wood, Wood et al. 2014). The most important benefit is the simplified ‘cut-and-paste’ 
mechanism that requires a single transposase for recognition of cognate inverted repeat 
sequences on flanking ends of DNA. This allows for direct transposition of DNA to DNA, 
without the requirement of additional co-factors. Additionally, the Himar1 hyperactive 
transposase has minimal target DNA specificity, inserting between A/T nucleobases (Benjamin 
and Kleckner 1992, Lampe, Churchill et al. 1996) and allowing for relatively non-specific 
insertion across an entire genome (Martinez and Delacruz 1990, Sota, Tsuda et al. 2007, Yahara, 
Didelot et al. 2014). The advantages of this system have proven to be beneficial for the study of 
pathogenesis in a diverse set of bacteria, including obligate intracellular organisms such as 
Coxiella and Ehrlichia. Research in Coxiella has demonstrated the use of Himar1 Tn 
mutagenesis to identify genes critical for cellular growth and division in vitro (Beare, Howe et al. 
2009, Newton, Kohler et al. 2014), whereas Tn studies in Ehrlichia revealed genes important for 
mammalian infection (Cheng, Nair et al. 2013). To date, however, a transposon mutagenesis 
system has not been developed for the globally prevalent and harmful obligate intracellular 
pathogen, Chlamydia. 
Chlamydia trachomatis is the most commonly reported sexually transmitted bacterial 
infection in the United States and worldwide. C. trachomatis infections result in a range of health 
issues from pelvic inflammatory disease and sterility, to blindness or pneumonia (Hillis, Owens 
et al. 1997, Stephens 1999). C. trachomatis contains a single, circular chromosome of ~1.04Mb 
and a plasmid of ~7,500 bp (Stephens, Kalman et al. 1998, Thomson, Holden et al. 2008). This 
relatively small chromosome is predicted to contain approximately 900 coding sequences, yet 
~35% of these encode for gene products lacking sufficient sequence similarity to support 
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functional annotation (i.e. hypothetical proteins) (Stephens, Kalman et al. 1998, Carlson, 
Porcella et al. 2005).  
In order to study in vivo pathogenesis of this important human-adapted organism, the 
mouse-adapted C. muridarum has historically been employed. In mice, C. trachomatis 
establishes poor infections and lacks ascension to the upper genital tract, as is common with 
human female infections, whereas C. muridarum readily ascends to the upper genital tract and 
establishes many of the post-infection physiognomies observed in human pathology. C. 
trachomatis and C. muridarum share nearly 98% of their genetic makeup which allowed for 
interchangeability during a mouse infection model of pathogenesis in the past (Stephens, Myers 
et al. 2009). Research has since identified that the majority of genetic variability between the two 
species occurs within the plasticity zone (PZ)—a region where many genes associated with 
tissue tropism, host speciation, and infectivity are believed to be located (Rajaram, Giebel et al. 
2015). For example, within the PZ of C. trachomatis are genes required for tryptophan synthesis 
that may account for tissue tropism, overcoming the host IFN-gamma response’s depletion of 
intracellular tryptophan levels; whereas mice lack this IFN response, C. muridarum lacks this trp 
operon. Similarly, the C. muridarum PZ contains three large cytotoxins of unknown function, 
hypothesized to play a role in ascension in the mouse vaginal-infection model; two of these are 
deleted from the C. trachomatis PZ and the remaining cytotoxin is fragmented, assumed to 
produce no functional gene product (Rajaram, Giebel et al. 2015). It is hypothesized that these 
genetic differences within the PZ prevent interchangeability of these species, especially when 
analyzing correlates contributing to different pathologies during mammalian infections. 
Enabled by the discovery of a method for transformation and effective selectable 
antibiotic markers (Wang, Kahane et al. 2011), there has been a recent surge of molecular tools 
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and methods developed for genetic manipulation in Chlamydia (Johnson and Fisher 2013, 
Wickstrum, Sammons et al. 2013, Bastidas and Valdivia 2016, Hooppaw and Fisher 2016). 
TargetTron (Johnson and Fisher 2013) and allele specific recombination (Binet and Maurelli 
2009, Mueller, Wolf et al. 2016) are two tools that have been developed for targeted gene 
disruption and have enormous potential for functional studies and phenotype associations of 
candidate genes. However, for random mutagenesis and unbiased discovery strategies, only 
chemically induced mutagenesis has been developed (Kari, Goheen et al. 2011, Nguyen and 
Valdivia 2014, Kokes, Dunn et al. 2015). This strategy has been effectively employed to 
introduce multiple base mutations, including non-sense mutations, supporting an association of 
many gene products with noteworthy alterations of physiological pathways (Kokes, Dunn et al. 
2015). While chemical mutagenesis is effective, certain limitations are associated, including the 
acquisition of multiple mutations. This can diminish the ability to correlate a phenotype to a 
particular genetic disruption. Furthermore, identifying the mutations requires whole-genome 
sequencing and revertants or compensatory mutations may be acquired during continued 
passaging. Thus, the development of a random single-insertion system, such as Himar1 
transposon containing a selectable marker, would allow for a straightforward generation of stable 
single site mutations, a simplistic identification of insertion sites, and the feasibility to screen for 
associated phenotypes. 
Herein, we describe the development and application of a novel Himar1 Tn system for C. 
trachomatis and C. muridarum. Through this innovative mutagenesis technique, the hyperactive 
C9 Himar1 transposase was demonstrated to be functional, successfully inserting either the β-
lactamase bla gene (C. trachomatis) or the chloramphenicol resistant cat gene (C. muridarum) 
into the respective chromosomes and conferring resistance. Relatively small libraries of Tn 
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insertion mutant strains were generated demonstrating that numerous coding regions were 
disrupted. Most insertion mutants exhibited a phenotype similar to wild-type, indicating that 
these gene products are not critical for in vitro cell-culture growth. Between the two libraries, 
four disruption mutants were found to have a role in establishing infections in mice 
transcervically infected with C. trachomatis, while two disruption mutants from the C. 
muridarum library displayed a decrease in recoverable organisms after a vaginal infection. These 
libraries offer a number of highlights to the field including identification of gene products 
essential for mammalian infection, potentially detecting species-specific mechanisms for 
infectivity, and distinguishing targets for directed mutagenesis in order to assess comparable 















Methods and Materials 
 
Chlamydial strains and propagation. C. trachomatis serovar L2 434/Bu and C. muridarum Nigg 
were propagated from L929 mouse fibroblast cells (ATCC CCL-1) using RPMI medium 1640 
(Invitrogen, Grand Island, NY) supplemented with 5% Heat-inactivated FBS plus 10µg/mL 
gentamycin (Fisher Scientific, Pittsburg PA). Briefly, L929 monolayers were grown to 
confluency in spinner flasks (~8x105 cells/mL) and infected with purified EBs. Cultures were 
allowed to grow for up to 48 hours at 37°C, 5% CO2. Percent infectivity was assayed by IFA 
microscopy (described below). EBs were harvested as previously described (Mukhopadhyay, 
Clark et al. 2004) using a series of centrifugation and sonication steps to disrupt the host-cells 
and release EBs. Once isolated, EBs were either frozen immediately or further purified using 
Omnipaque™ (Barrington, IL) and ultracentrifugation. All EBs were stored in sucrose phosphate 
glutamate (SPG) media at -80°C. Clonal isolates were obtained as previously described 
(Suchland, Bourillon et al. 2005).  
 
Development of pCMA and pCMC5M transformation plasmids. pUC19 (GenBank Accession # 
L09137) was used as the initial backbone for generating pCMA. The C9 hyperactive transposase 
was amplified from pBADC9 (kind gift from D. Lampe; Duquesne University (Lampe, Akerley 
et al. 1999)) and cloned between the EcoRI and AatII sites. An EagI site was incorporated for 
subsequent promoter cloning. Initially, a vector (pCMT) that contained a tetracycline encoding 
transposon was generated for application in C. muridarum using pACYC184 (GenBank X06403) 
as a template. Primers incorporated Himar inverted repeats and restriction sites for cloning into 
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the XmaI site. To remove the β-lactamase gene encoded on pUC19, the transposase, tetracycline 
transposon, and ori region were amplified with primers containing NcoI sites for self-ligation. 
Ligase independent cloning and HindIII sites were used to replace the tetracycline transposon 
with one encoding the β-lactamase and associated promoter from pSW2 (Wang, Kahane et al. 
2011). To assist with selective expression of the transposase within Chlamydia, and less during 
plasmid propagation in E. coli, the chlamydial CT559 promoter and ribosomal binding sites were 
cloned upstream of the transposase gene using the EagI site (Hefty and Stephens 2007). 
pCMC5M plasmid was generated in which chloramphenicol resistance (camR) replaced the β-
lactamase gene. Graphical plasmid depictions (Figure. 3.1) were generated using Savvy Scalable 
vector graphics (Bond and Naus 2012). 
 
Transposon mutagenesis. Transformation of C. trachomatis was modified from previously 
described methods (Wang, Kahane et al. 2011). L929 cells were seeded to confluency in 6-, 12- 
or 24-well plates and allowed to adhere overnight. EBs and pCMA plasmid DNA were combined 
in CaCl2 buffer to an MOI of 5 and incubated for 30 minutes at room temperature (RT).  The 
mixture was added to 1X SPG before being overlaid on the L929 monolayer. Plates were spun at 
550xg for 30 minutes at RT. Fresh RPMI supplemented with FBS, gentamycin and 1µg/mL 
cyclohexamide was added and plates were incubated at 37°C, 5% CO2 overnight. 1µg/mL 
ampicillin (Fisher Scientific, Pittsburg, PA) was then added for antibiotic selection at 16 hours 
post-infection. Cultures were kept under antibiotic selection and serially passaged every ~36 hpi. 
48 hrs after the final passage, EBs were harvested for identification of insertion site and 
subsequent analyses. C. muridarum transposon mutants were generated in the Hybiske lab at the 
University of Washington and were kindly sent for in vivo analysis. 
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Arbitrary PCR and confirmation of insertion sites. The Tn insertion site was determined using 
modified arbitrary PCR as previously described (Caetano-Anolles 1993, O'Toole, Pratt et al. 
1999). Briefly, two rounds of PCR were performed using Taq polymerase. The first round was 
performed as follows: PCR along with round 1 ARB PCR primers (Table 3.1) with an annealing 
temp of 30°C for 6 cycles and 50°C for 30 cycles. PCR product was purified using a QIAquick 
clean up kit (Qiagen, Valencia, CA).  The resulting product was used in the second round of PCR 
using round 2 ARB PCR primers and standard protocol. The final product was run on a 1.5% 
agarose gel and the resulting bands excised and sequenced. Sequences matching potential 
insertion sites were subsequently confirmed using PCR with primers designed to flank the 
suspected insertion site (Table 3.1).  These amplicons were also run on a 1.5% agarose gel and 
the subsequent bands were sequenced to confirm the Tn insertion. 
 
Digital Droplet PCR to identify single Tn insertions. Digital droplet PCR (ddPCR) was utilized 
as a highly sensitive method for determining the number of insertion sites of the transposon 
within the chromosome and was performed as per the manufacturer’s instructions (Bio-rad, 
California). Mutant strains were harvested as described above and DNA was isolated and 
purified using the Qiagen Blood and Tissue kit (Qiagen, California). Primers were designed for 
the β-lactamase insertion sequences as well as 16S rRNA and tsp (CT441, Table 3.2).  PCR 
Reactions were run using either EvaGreen® in an oil-in-water droplet emersion generated using 




Table 3.1: Primers used to identify and confirm Tn insert. 
Transposon Flanking PCR (5'-3') 
Gene Primer Sequence and Designation 
Round 1 ARB primers CTATGGATGAACGAAATAGACAG GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT 
 

























































10 minutes, followed by 40 cycles of 94°C for 30 seconds, and 60°C for 1 minute.  Finally, 
reactions were held at 98°C for 10 minutes followed by cooling to 4°C.  Once complete, 
fluorescence of individual droplets was calculated using a droplet reader (Bio-rad, California) 
and analyzed using the QuantaSoft Software (Bio-rad, California). Data is reported as a ratio of 
copies/µL for respective primer comparisons.  
 
Immunofluorescence microscopy. For determination of percent infectivity, calculating infective 
titer and phenotypic analysis, IFM was performed as previously described (Osaka, Hills et al. 
2012).  L929 cells were grown to confluency in an 8-well ibiTreat µ-Slide (Ibidi, Martinsried, 
Germany) and were infected with respective C. trachomatis/Tn mutants. At ~24 hpi, infected 
cells were fixed with 100% methanol for 10 minutes at RT. Cells were washed once with HBSS 
and again with PBS then stained using either 180µl of the MicroTrack C. trachomatis culture 
confirmation test (Syva Co., Palo Alto, CA) or Virostat Chlamydia MONOTOPE Fluorescein 
Conjugated IgG1 LPS, diluted 1:40 in PBS for 1 hour and 50 minutes RT in the dark or 
overnight at 4°C. 20µl of 1µM 4’, 6-diamidino-2-phenylindole (DAPI) diluted 1:100 in PBS was 
then added to wells and allowed to stain for 10 minutes, RT in the dark. Stain was then removed, 
and the cells washed with PBS. For in vitro phenotypic analysis, a final overlay of Vectashield 
antifade mounting medium (Burlingame, CA) was added and slides were stored at 4°C in the 
dark until imaged. Cells were visualized on an Olympus IX81/3I spinning disk confocal inverted 
microscope at 150X magnification and captured on an Andor Zyla 4.2 sCMOS camera (Belfast, 
Northern Ireland). Microscope and camera were operated using SlideBook 6 software (Intelligent 
Imaging Innovations, Denver, USA). Exposure time remained consistent for all fields captured, 





Table 3.2. Primers used for Droplet Digital PCR 
 
 
Droplet Digital PCR (ddPCR) (5'-3') 
 
Gene Primer Sequence and Designation 








C. trachomatis secY 
TAAAAAGCCGTGTCATTCGTCC 
TCGGCTTCAATCATTGTACAGC 
C. trachomatis secY probe /56-FAM/TAATTTACG/ZEN/CTTCCCTTGATCCGGC/3IABkFQ/ 
C. muridarum rpoB: 
CAGATGGGAGGACARAGATTCGGGG 
TGAACGACTCAGGCGTTCCAGAAC 




Murine rpp30 probe /5HEX/TGAGACGAGTCCTGAGTCTC/3IABkFQ/ 
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seven Z stack images at 0.3µm apart were taken per cell imaged.  Images were processed in 
SlideBook 6 and a No Neighbors Deconvolution with a subtraction constant of 0.4 was applied 
to all images. For calculations of infective titers, a final overlay of 0.1M tris-glycerol was added 
and cells were imaged using an Olympus IX81 inverted epifluorescence microscope. For each Tn 
mutant, IFU/µL was calculated and used as the pre-infection titers. 
 
In vivo mouse infections. Female C57BL/6 mice 6-8 weeks old were purchased from Jackson 
Laboratories and housed in accordance with the University of Kansas Institutional Care and Use 
Committee requirements. Mice were treated subcutaneously with 2.5mg 
Medroxyprogesteronacetat (Depo-Provera, Pfizer, NY) upon arrival (day -7).  Fresh aliquots of 
WT C. trachomatis or C. trachomatis Tn mutant stocks were diluted in sucrose-phosphate 
glutamic-acid (SPG) buffer and kept on ice until use. Using a non-surgical embryo transfer 
device (NSET, Lexington, KY), mice were inoculated transcervically with 10µL diluted stock 
(final concentration ~5x105 IFU/mouse) by inserting the device into the genital tract beyond the 
opening of the cervix. Mice were monitored to ensure no dose was secreted from the animal. For 
C. muridarum vaginal infections, WT or Tn mutants were diluted to a final dose of 1x105 
IFU/5µL in SPG and kept on ice until use. Animals were swabbed using sterile nasopharyngeal 
swabs (Puritan,	   Guilford, Maine) prior to dosing. Using a P10 pipette, sterile tips were inserted 
until reaching the cervix of the animals, slightly withdrawn and inoculated. Animals were held 
briefly with the tip still inserted to ensure no dose was secreted or pulled out upon removal of the 
pipette tip. Post-infection titers were calculated for each dose by infecting L929 monolayers with 
serial dilutions of each dose. Staining and IFU/µL calculations were performed as described 
above. 
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ddPCR assessment of Chlamydia infection in vivo. Infected mice were humanely euthanized five 
days post-infection (C. trachomatis transcervical infections) or nine days post-infection (C. 
muridarum vaginal infection) and the genital tracts were collected in SPG. Organs were 
homogenized using a rotor/stator homogenizer (Biospec, Bartlesville, OK). 100uL aliquots were 
frozen at -20°C until use. Remaining stocks of homogenized tissues were stored at -80°C. DNA 
isolation on the 100uL aliquots was performed using the DNA isolation using the DNeasy Blood 
and Tissue Kit (Qiagen, Valencia, CA). Isolated DNA was then used to run droplet digital PCR 
similarly as described above. Primers and probes for C. trachomatis secY, C. muridarum rpoB 
and mouse rpp30 can be found in Table 3.2. ddPCR Supermix for Probes was used to set up PCR 
reactions and Oil-for-Probes droplet emersions were generated using the droplet generator 
cassette (Bio-rad, California). The PCR conditions are as follows: 95°C for 10 minutes, 40 cycles 
of 94°C for 30 seconds, and 98°C for 10 mins followed by cooling to 4°C.  Fluorescent reads of 
individual droplets were calculated after PCR using the QX200 droplet reader (Bio-rad, 
California). Data was analyzed using the QuantaSoft Software (Bio-rad, California) and reported 
as a ratio of Chlamydia DNA to host DNA (secY or rpoB/rpp30, copies/µL). Box and whisker 
scatter plots were generated in Graphpad Prism 7 and recoverable organisms were compared 








Development of transposon plasmid.  
Typical transposon mutagenesis strategies include the introduction of two plasmids: one 
encoding the transposase and another containing the transposon. The intent of keeping these 
components separate is to reduce the acquisition of deleterious mutations in the transposase or 
transposon during plasmid propagation in Escherichia coli. Due to the very low transformation 
efficiencies in Chlamydia (Beare, Sandoz et al. 2011, Bastidas and Valdivia 2016, Hooppaw and 
Fisher 2016), it was necessary to design a plasmid that contained both components, yet limit the 
expression of the transposase in E. coli. The transposon plasmids, termed pCMA and pCMC 
(Chlamydia Mariner and Chlamydia Mariner Chloramphenicol plasmids, Figure 3.1) were 
designed to encode the widely utilized C9 Himar1 transposase. To assist with selective 
expression of the transposase within Chlamydia, and less during plasmid propagation in E. coli, 
the chlamydial CT559 promoter and ribosomal binding sites were cloned upstream of the C9 
transposase. This promoter demonstrated activity in Chlamydia, but limited transcriptional 
activity in E. coli (Wickstrum, Sammons et al. 2013). pCMA also contained the β-lactamase 
encoding gene preceded by regulatory components previously demonstrated to be effective in the 
chlamydial shuttle vector pSW2 (Wang, Kahane et al. 2011), whereas pCMC contained the GFP-
fused chloramphenicol resistance gene. Both antibiotic resistance genes were cloned with 
flanking inverted repeats for recognition and transposition by the Himar1 transposase. 
Additionally, the colE1 origin of replication from E. coli was used to enable propagation in E. 





Figure 3.1 Plasmid maps of pCMA and pCMC5M. The C9 hyperactive variant of the 
Himar1 transposon was cloned downstream of the Chlamydia CT559 promoter. A) β-
lactamase and associated promoter was cloned from the chlamydial shuttle vector 
pGFP::SW2 (Wickstrum, Sammons et al. 2013). B) GFP-fused chloramphenicol resistance 
replaces the β-lactamase and promoter. Both antibiotic markers are flanked by Himar1 
inverted repeats to generate the transposon. 
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Transposon mutagenesis with pCMA yields stable Tn insertion mutants.  
The pCMA plasmid was used in a standard transformation procedure using β-lactams for 
selection in C. trachomatis. This procedure typically requires three passages under antibiotic 
selection (infection-growth-lysis-reinfection) to ensure that resulting organisms contain β-
lactamase coding DNA. Clonal isolates from this resistant culture were obtained and expanded. 
PCR confirmed the presence of the β-lactamase gene, yet PCR was negative for the presence of 
the transposase (data not shown) supporting the loss of the non-replicative pCMA plasmid. To 
identify the site of potential transposon insertion, arbitrary PCR (O'Toole, Pratt et al. 1999) was 
performed and sequence analysis of individual amplicons indicated the presence of the β-
lactamase transposon. Subsequent PCR with primers flanking the possible transposon insert 
supported the insertion of ~1400 bp (Figure 3.2) Moreover, only this larger amplicon size was 
observed, supporting the clonality of this sample (i.e. no wild-type or alternate Tn insertion 
mutants present). Sequencing of the amplicons confirmed the presence and provided the exact 
location of the transposon insertion between a TA for each insertion site (Figure 3.3,). Similar 
arbitrary PCRs were performed on C. muridarum Tn mutants using the pCMC5M plasmid and 
exact location of the transposon insertion was identified (Figure 3.4) For both libraries, whole-
genome sequencing was also performed to confirm singularity and location of Tn insertion (data 
not shown).  
In order to decrease the potential for normal growing mutants to outcompete fitness 
compromised mutant clones in a mixed infection, as well as to evaluate transformation and 
transposon efficiency, two transformation reactions (DNA and EBs) were mixed and incubated 
before being split into individual 12-well plates. Each well was passaged twice with selection 
and after the second passage; cultures were allowed to continue with daily monitoring of  
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Supplementary Figure 1. PCR confirmation of Tn insertion location. DNA was extracted from 
each Tn mutant and analyzed byPCR using primers flanking the proposed Tn insertion sequence. 
A single band of ~2.0 kbp was observed indicating the presence of the Tn with flanking gene 
overhangs (size of WT gene, ~0.5kbp and Tn insertion sequence, ~1.4 kbp). Absence of lower 
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Figure 3.2. PCR confirmation of Tn insertion location. DNA was extracted from each C. 
trachomatis Tn mutant and analyzed by PCR using primers flanking the proposed Tn 
insertion sequence. A single band of ~2.0 kbp was observed indicating the presence of the Tn 
with flanking gene overhangs (size of WT gene, ~0.5kbp and Tn insertion sequence, ~1.4 




C. trachomatis growth. Within 3 days of cultivation, C. trachomatis growth was observed in 5 or 
6 wells of separate 12 well plates. Growth of one sample (CT696::Tn) took 8 days before growth 
was observed and required addition to fresh monolayers to allow continued propagation. These 
data support that transformation efficiency in C. trachomatis is very low (estimated <1 IFU/µg 
DNA) as well as the possibility that C. trachomatis is less tolerant to disruptive insertions. These 
data also support that growth observed in each of these wells is likely clonal.  
While arbitrary and flanking PCRs indicated the presence of a single transposon insertion 
in C. trachomatis mutants, it appeared several C. muridarum Tn mutants potentially had double 
inserts. Due to the ease and accessibility of our collaborators to whole genome sequencing 
(WGS), follow-up sequencing on many C. muridarum Tn mutants further identified four isolates 
with double insertions. For one isolate, only one copy of the Tn (chloramphenicol) gene is 
present, however, the position upon which it inserted resulted in a disruption of two overlapping 
genes: TC0368 and TC0369 (Figure 3.5A). In our laboratory, to evaluate the possibility of 
additional transposon insertions, droplet digital PCR was implemented. Droplet digital PCR 
(ddPCR) is a relatively new technology, which allows for accurate quantification of the copy 
number for individual alleles (Roberts, Last et al. 2013). It also requires very little sample 
relative to other methods. ddPCR was initially performed on CT392::Tn and wild-type C. 
trachomatis. C. trachomatis encodes for two copies of 16S rRNA, providing an internal control 
for the detection of multiple alleles, and tail-specific protease (tsp) was used as a single-copy 
allele control. As Figure 3.5B indicates, allele quantification of 16S and tsp for wild-type and 
CT392::Tn resulted in 16S/tsp allele copy ratios near 2. However, when β-lactamase (bla) allele 
copies were enumerated and compared to tsp, these ratios were near 1, supporting the presence 






Figure 3.3. Himar1 transposon insertions sites for Chlamydia trachomatis mutants.  A) 
Both C. trachomatis serovar D (CT) and LGV (CTL) gene nomenclature indicating site of Tn 
insertion and immediate flanking genes (gray) are shown. Precise insertion of transposon (red) 
and flanking sequence (black) including the A/T upon which the transposon inserted are 
highlighted. B) Diagram showing relative insertions (red) within the Chlamydia genome 
indicating the dispersion of Tn insertions.  
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transposon mutant clones revealing that all samples had bla to tsp ratios close to 1 (range 0.7 – 
1.15; Figure 3.5C), also supporting the presence of a single transposon insertion in each clone.  
In total, 13 unique C. trachomatis Tn mutants and 26 C. muridarum Tn mutants were 
generated within a variety of genetic targets (Figures 3.3 and 3.4). Within the C. trachomatis 
library, all but one (intergenic region CT383/4::Tn) of these transposon insertions occurred 
within a coding region, likely disrupting the function of the encoded gene product. Moreover, the 
insertions are occurring throughout the genome with slight enrichment of 5 Tn insertions within 
~100 kb near 0.7 Mb site (Figure 3.3B). Four Tn insertions occurred within genes encoding 
hypothetical proteins: CT036, CT392, CT550, and CT696. Among functionally annotated genes, 
insertions occurred in a range of genes including those encoding a phosphate responsive ATPase 
(CT015), FAD-dependent monooxygenase (CT148), MAC/Perforin family protein (CT153), 
DNA repair mechanisms (CT333), competence factor (CT339), SAM-dependent 
methyltransferases (CT404), apoptosis inhibitor (CT819), and deubiquitinase (CT868). 
 Within the C. muridarum Tn library, all but four isolates resulted in insertions within 
coding regions. Seven of these occurred within hypothetical proteins, including the same 
deubiquitinase observed to contain an insert within the C. trachomatis library (CT868/TC0259). 
Among isolates containing double inserts, a region spanning >150kbp is present between each 
insert site and two of these isolates contain insertions disrupting genes within the plasticity zone: 
a region of high variability hypothesized to be the determinant for virulence and host-tropism. 
Further, three inserts disrupted polymorphic membrane proteins: surface exposed proteins 









Figure 3.4. Himar1 transposon insertions sites for Chlamydia muridarum mutants.  A) C. 
muridarum Nigg gene nomenclature indicating site of Tn insertion and immediate flanking 
genes (gray) are shown. Precise insertion of transposon (red) and flanking sequence (black) 
including the A/T upon which the transposon inserted are highlighted. B) Diagram showing 









Figure 3.5. Assessment of single vs. double Tn insertions. A) Whole genome sequencing of 
C. muridarum Tn mutants confirmed the presence of double inserts in 4 isolates. Gene 
nomenclature indicating site of Tn insertion and immediate flanking genes (gray) are shown. 
Transposon (red) and flanking sequence (black) including the A/T upon which the transposon 
inserted are highlighted. Distance between genes containing inserts is shown as double-
backslashes with the length between in kbp. TC0368 and TC0369 genes overlap, resulting in a 
double insert at the same region (only 1 Tn). B) Ratio of allele copy numbers for CT392::Tn. 
Genomic DNA was isolated and subjected to ddPCR with primers specific for tsp,16S, and 
bla. Data are reported as mean and SD of allele copy number ratios. As expected, bla 
generated an equal one-to-one ratio with tsp, indicating the presence of only one Tn insertion 
per genome. The absence of endogenous bla is observed (ND: None detected). Statistical 
difference in measured ratio of 16S/tsp to bla/tsp within CT392::Tn was determined by 
unpaired t-test (*p=0.004). C) Copy numbers for all C. trachomatis Tn mutants. Subsequent 
ddPCRs were performed on all remaining Tn mutants. Data are reported as allele copy 
number ratio of bla/tsp. 
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General growth characteristics of transposon mutants.  
Following passaging and confirmation of transposon insertions, mutant C. trachomatis 
inclusions and bacterial cell morphology were imaged and assessed by confocal microscopy. For 
most of the transposon mutants, inclusion and bacterial morphology yielded no apparent 
abnormalities (Figure 3.6). A notable difference in growth and inclusion morphology was 
observed for the clone containing a transposon insertion in the gene encoding the hypothetical 
protein CT696. This mutant appears to have a severely reduced ability to grow and form 
inclusions relative to wild-type C. trachomatis (Figure 3.7). Typically, growth and division of 
reticulate bodies are evident (Figure 3.7A, WT and 3.7B, CT696::Tn; white arrows), however, 
RBs from CT696::Tn are dispersed throughout the cytoplasm and do not appear to localize near 
the nucleus as generally observed in early inclusions (Figure 3.7B and 3.7C). Occasionally, 
bacteria appear to aggregate (Figure 3.7D; yellow arrow), exhibiting abnormal patterns within an 
inclusion, however, individual RBs retaining their expected coccoid morphology are still 
observed (Figure 3.7D; blue arrow). 
 
In vivo assessment of transposon infectivity and recoverable bacterial burden.  
As initial studies have elucidated, mouse infections with C. trachomatis L2 administered 
vaginally are readily cleared, does not cause pathology and rarely ascends to the upper genital 
tract—the biologically relevant site for mimicking human infections (Gondek, Olive et al. 2012). 
As such, the transcervical model was developed in which infective doses of C. trachomatis L2 
(434/Bu) are dispensed directly into the upper genital tract. These proof-of-concept experiments 
have shown that infections typically peak between days 3 and 6 post-infection and have cleared 





Figure 3.6. Confocal Microscopy of C. trachomatis Tn Mutants. L929 cells were infected 
with either WT C. trachomatis or respective Tn mutant. 24 hpi µ-slides were stained. 
Ampicillin (Amp) treated cells were included as a representative image of persistence found 
in non-transformed bacteria. Cells were viewed at 150X magnification with no Neighbors 
deconvolution and a subtraction of 0.4 in SlideBook. Blue: DAPI, nucleus; Red: Evan’s Blue, 






Figure 3.7. Confocal microscopy of CT696::Tn mutant. L929 mouse fibroblasts were 
infected with either C. trachomatis WT or CT696::Tn mutant. Infections were fixed at 24 hpi 
and immunofluorescently stained. Images were acquired at 150X magnification with 
deconvolution for enhanced image resolution. A) WT C. trachomatis inclusion showing 
normal RB division (white arrow). B) CT696::Tn showing normal RB division (white arrow). 
C) Dispersed localization of CT696::Tn within the cytosol. D) Aggregating form of 
CT696::Tn. Coccoid shaped RBs (blue arrow) are observed external to the aggregation 
(yellow arrow). Blue: DAPI, nucleus; Red: Evan’s Blue, cytoplasm; Green: MOMP, C. 
trachomatis organisms. Scale bar = 1µm. 
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C. muridarum, on the other hand, is capable of ascending to the upper genital tract 
rapidly after vaginal infections, and remains detectable far beyond 15 days post infection 
(Gondek, Olive et al. 2012). Therefore, to illuminate potential deficiencies of Tn mutants to 
establish infection, we utilized both models in which genital tracts of C. trachomatis infected 
mice were harvested on day 5, within the peak of WT L2’s dynamic range of infection, and C. 
muridarum infected mice were harvested on day nine post-infection. It is hypothesized the Tn 
insertion(s) within intergenic regions (CT383/4::Tn, TC0019/20::Tn, TC0080/1::Tn, 
TC0436/7::Tn, TC0913/4::Tn) may serve as an internal Tn-controls due to the lack of disruption 
within a coding region and, as such, any potential deficiencies due to the presence of the 
transposon itself will be observable using these mutants. Further, whole genome sequencing of 
the mutants confirmed any potential phenotypes observed are the result of Tn disruptions and not 
additional mutation incurred during propagation.  
As can be seen from Figure 3.8, the C. trachomatis intergenic disruption (CT383/4::Tn) 
showed no significant difference in detectable organisms as compared to WT C. trachomatis 
infection and serves as an effective control for comparison between Tn insertion mutants. Of the 
remaining 11 Tn mutants, two showed statistically significant decreases in detectable organisms 
from the uterine horns whereas two showed a decrease, albeit not statistically significant, as 
compared to the intergenic Tn control. Disruptions in a hypothetical-putative exported protein 
(CT036), the membrane attack complex (CT153) and the ChlaDUB1 deubiquitinase (CT868) 
showed nearly a half- to log-fold decrease in detectable organisms as compared to IGR. An 
mphA-FAD-dependent monooxygenase (CT148) showed a range of infectivity with one animal 
completely uninfected and three exhibiting WT levels of detectable organisms (Figure 3.8).  The 
mean detectable values for this group fall two-log below the means of both WT and IGR, the 
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most dramatic deficiency in detectable organisms. What remains unclear, however, is whether 
these Tn mutants deficient in infectivity are incapable of establishing infection altogether or 
whether the peak of infectivity is delayed; thusly future studies in which recoverable organisms 
are assessed at varying timepoints throughout an infection should be implemented. Similarly, 
infections using a higher IFU will provide strong support for the mutants’ inability to establish 
infection outright.   
Due to the consistent expansion of the C. muridarum library taking place at the Hybiske 
Lab, in vivo analyses remain ongoing. Preliminary data from seven of these Tn mutants, 
however, identified two potential candidates with deficiencies in mammalian infections: 
TC0657::Tn and a double-insert mutant TC0257/TC0431::Tn (Figure 3.9). Similar to C. 
trachomatis infections, the intergenic Tn mutant TC0436/7::Tn showed no significant difference 
in detectable organisms as compared to WT C. muridarum. A Tn insertion within the glucose-6-
phosphate isomerase (TC0657) showed a significant defect in recoverable organisms from the 
uterine horns, however no other mutants showed similar deficiencies.  
Perhaps the most intriguing of the C. muridarum Tn mouse infection data are the animals 
infected with the double-insert isolate, TC0257/TC0431::Tn.  As can be seen in Figure 3.9, 
nearly all animals within this group display a defect in infectivity, with the respect of two 
animals. These two mice displayed hyper-infections with detectable organisms as high as the 
ovaries (data not shown). At the time of infection, it was not known that this isolate contained a 
double insert; rather it was presumed to only contain one or the other. To date, it still remains 
unclear whether the sample contains two inserts within one genome or a mixed population with 
single and double inserts; current efforts are underway to plaque isolates from the uterine horns 
of these animals to determine if they contain one or both disruptions. While it is known 
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Chlamydia accumulates glycogen for metabolism, the regulation of this metabolism remains 
elusive; recent studies have shown that even when grown in variable media, expression of many 
gluconeogenic genes remain constant (Iliffe-Lee and McClarty 2000) and thus, suggest a 
disruption in TC0257 (glgB) may have a dramatic effect in growth of the organisms. Equally, the 
chlamydial MACPF (TC0431) is a highly conserved protein within the plasticity zone which 
may serve as a potential virulence factor (Taylor, Nelson et al. 2010) that, if disrupted, may 
explain a dramatic decrease in the organism’s ability to establish infection in the mouse model. 
To fully interpret the effect of these mutants the determination of double vs. single/mixed 
insertion mutants must be identified. Secondly, the animals displaying a decrease in recoverable 
organism should be assessed to determine if one or both insertion disruptions remain and finally, 
organisms from the two hyper-infected mice will need to be assessed for the potential of variable 
genotypes as compared to the remaining animals within this group: either through compensatory 








































































Figure 3.8. In vivo infections using C. trachomatis Tn mutants with a transcervical mouse 
infection model. Female C57BL/6 mice were infected transcervically with 5x10
5
 IFU of 
either WT C. trachomatis or one of the Tn mutants listed above. Five days post infection, 
genital tracts were harvested and DNA from uterine horns purified. Droplet digital PCR was 
used to calculate Chlamydia DNA relative to host and ratios are shown as box-and-whisker 




























































Figure 3.9. In vivo infections using C. muridarum Tn mutants with a vaginal mouse 
infection model. Female C57BL/6 mice were infected vaginally with 1x10
5
 IFU of either WT 
C. muridarum or one of the Tn mutants listed above. Nine days post infection, genital tracts 
were harvested and DNA from uterine horns purified. Droplet digital PCR was used to 
calculate Chlamydia DNA relative to host and ratios are shown as box-and-whisker with 





There have been many recent firsts in the area of genetically modifying Chlamydia 
trachomatis, including chemical mutagenesis (Kari, Goheen et al. 2011, Nguyen and Valdivia 
2014, Kokes, Dunn et al. 2015), group II intron gene disruption systems (Johnson and Fisher 
2013), allele replacement (Binet and Maurelli 2009, Mueller, Wolf et al. 2016), and inducible 
gene expression (Wickstrum, Sammons et al. 2013, Bauler and Hackstadt 2014). The 
development and validation of a transposon mutagenesis system using the Himar1 transposase, 
as presented here, provides another first and a key advancement in the Chlamydia field. The data 
presented demonstrates that the transposase is functional within Chlamydia and the use of the 
non-replicative plasmid results in mutant C. trachomatis and C. muridarum clones containing 
mostly single genomic insertions. The insertion sites are readily discovered and characterized by 
common PCR-sequencing based techniques. Additionally, these insertion mutations are stable 
and can be maintained under selective pressures, limiting chances of reversion. A primary 
benefit of this limited insertion, random mutagenesis approach, is the ability to associate a 
specific genetic disruption to a resulting phenotype. This approach is among the more prominent 
and successful techniques for microbiological discovery. As demonstrated by the insertion 
disruption in the MACPF (CT153/TC0431) in both C. trachomatis and C. muridarum and 
subsequent biological studies related to mammalian infection in Chlamydia presented here, the 
scientific contributions of this molecular tool and approach are expected to be very useful for 
Chlamydia studies as well. 
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Notwithstanding these benefits, the present study also highlights the extremely low level 
of transformation efficiency associated with Chlamydia and the current limitation for large-scale 
transposon mutagenesis studies. In these studies, approximately five to six transposon insertion 
clones were obtained per transformation. This low transformation efficiency may suggest an 
extreme density of genes essential for growth and completion of the chlamydial developmental 
cycle within cell culture conditions (in vitro). However, recent random chemical mutagenesis 
study by Valdivia and colleagues (Nguyen and Valdivia 2014) reported that 84 protein-coding 
genes incurred a non-sense mutation with limited growth effect, albeit within the context of other 
mutations. This supports that a density of essential genes is likely not the limiting factor for the 
few transposon mutant clones generated per transformation. Moreover, four genes 
(CT036/CTL0291, CT333/CTL0587, CT339/CTL0593, and CT392/CTL0648) within this 
transposon mutant library were also disrupted in the chemical mutagenesis study, suggesting that 
the disruption of many more genes may be tolerated in vitro (i.e. cell culture). This also suggests 
that these non-essential in vitro genes may be more critical during the more evolutionary shaping 
environment of mammalian infection. Indeed, whereas CT036::Tn, CT148::Tn, CT153::Tn and 
CT868::Tn did not show obvious growth defects in vitro, all four of these mutants showed 
decreased ability to establish infection in the mouse transcervical model and designates a 
baseline for the biological processes these gene products may be essential in. Further the 
initiation of in vivo studies with the C. muridarum library will be of particular significance to our 
understanding of Chlamydia pathogenesis, using these Tn mutants to investigate the relative 
importance of particular gene products during ascension and potential differences in host-
tropisms and co-evolutionary development within the mouse. 
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 This study generated a relatively small library of thirteen transposon insertion mutants in 
C. trachomatis and 26 mutants in C. muridarum that support the majority of disrupted gene 
products are not essential for in vitro growth, with the exclusion of a disruption in hypothetical 
protein, CT696. These libraries contain a number of noteworthy disruptions that could have been 
expected to have a more observable effect on bacterial growth in cell culture conditions. CT868 
encodes a putative deubiquitinase termed Cdu1 and the Tn inserted in the carboxyl-terminus 
coding region rendering a 297 a.a. truncation (401 a.a. wild-type sequence). Chlamydia encode 
two deubiquitinating proteins, Cdu1 and Cdu2, which both contain the same catalytic triad of 
SUMO-specific proteases and are capable of binding probes specific of deubiquitinating 
enzymes (Misaghi, Balsara et al. 2006). The CT868::Tn insertion occurs just before this active 
site and is expected to disrupt the deubiquination activity of this protein. Cdu1 has been 
demonstrated to be capable of inhibiting host NF-κB: a central regulator of numerous immune 
responses including cytokine secretion and T-cell proliferation, and a vital defense against 
intracellular pathogens (Misaghi, Balsara et al. 2006, Le Negrate, Krieg et al. 2008, Gerondakis, 
Fulford et al. 2014). The targets and biological role of Cdu2 remains unknown and may provide 
redundant function to explain the absence of observable fitness defects in vitro. This Tn insertion 
CT868::Tn, will enable future studies to evaluate the potential redundancy and protein target 
specificity for Cdu1 and Cdu2, as well as their effect on infectivity and pathogenesis in an 
animal model. Further, the C. muridarum Cdu2 ortholog TC0259 also incurred an insertion, 
albeit outside the proposed active site of the protein. This disruption appeared to have no effect 
on the growth or infectivity of the organism in vitro or in vivo, supporting the proposed 
essentiality of an intact active site for a functional gene product.  
 
	  111	  
Another notable disruption that was associated with no observable growth defect was 
CT819::Tn. CT819 encodes a protein with a domain containing high similarity to the apoptosis 
Bax inhibitor-1. Through Bax-1 inhibition, not only is Bax-mediated apoptosis halted, but 
intracellular defenses, such as reactive oxygen levels and cytosolic acidification, are abrogated 
(Robinson, Clements et al. 2011). Given previous observations related to apoptosis inhibition 
during Chlamydia infections (Byrne and Ojcius 2004), this insertion might be expected to result 
in a more noticeable effect on growth; however, microscopic analysis revealed no obvious defect 
in inclusion size or bacterial morphology (Figure 3.6). Protein topology analysis indicated that 
CT819 is a seven-pass integral membrane protein with no signal peptide (data not shown). 
Furthermore, it does not appear to encode a calcium-binding motif, as most BI-1 proteins are 
predicted to mediate calcium flux. This may suggest that in spite of proposed homology, CT819 
may have other roles in chlamydial pathogenesis besides apoptosis inhibition. Along these lines, 
studies have shown that Chlamydia is capable of upregulating Mcl-1, an anti-apoptotic member 
of the Bcl-2 family, which may provide sufficient anti-apoptotic activity in vitro and account for 
the negligible deficiency of CT819::Tn growth in these conditions (Rajalingam, Sharma et al. 
2008).  
Phenotypically, the most striking was the observable growth and morphological 
deficiencies of CT696::Tn (Figure 3.7). First classified as a phenotypic slow-grower, CT696::Tn 
took approximately 8 days until visible inclusions were detected by phase microscopy and 
subsequent analysis by confocal microscopy identified a decreased number of RB/EBs as well as 
the absence of nuclear localization typically observed with Chlamydia inclusions. Due to genetic 
placement near the known type three secretion (T3S) effector protein CT694, it has been 
hypothesized that CT696 may be part of an operon, playing a role in T3S; however, recent work 
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suggests this may not be the case. Using a heterologous T3S system with Yersinia enterocolitica 
(da Cunha, Milho et al. 2014, Mueller and Fields 2015), secreted levels of the CT696 
hypothetical gene product were not observed and Fields et al. showed transcription of CT696 
was found to occur independent of CT694. CT696 is a Chlamydiaceae conserved hypothetical 
protein with no sequence or conserved domains shared outside of this family. Using the bacterial 
localization tool PSORTb (Gardy, Laird et al. 2005), CT696 was predicted as neither a 
membrane-bound or T3S protein but as a cytosolic protein. While more in-depth analysis is 
required to evaluate the role and function of CT696 on growth and inclusion formation, this 
observation provides support for these efforts as well as a good example of the utility of this 
transposon approach for the discovery of genes important to the biology of Chlamydia.  
Finally, whereas limited in vitro analysis of growth and development have been 
completed, the few C. muridarum Tn mutants that have been evaluated in vivo showed one 
mutant with decreased recoverable organisms, TC0657, a gluose-6-phosphate isomerase. The 
carbon metabolism pathways in Chlamydia have perplexed researchers for years and recent 
studies have once again shifted the paradigm via discovery of actively transcribed metabolic 
enzymes, unaltered growth phenotypes when host ATP acquisition is restricted, and evidence of 
chlamydial metabolism present during active growth whereas host ATP/ADP exchange is 
dynamic during initial and persistent infections (Tipples and McClarty 1993, Iliffe-Lee and 
McClarty 1999, Shaw, Dooley et al. 2000, Gérard, Freise et al. 2002). As such, while there are 
studies undergoing to assess growth and development of the TC0657::Tn mutant in vitro, it is 
fathomable that a disruption of the glucose-6-phosphate isomerase would result in altered 
infectivity in vivo. These studies will thus serve to further strengthen an argument for energy 
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acquisition as it relates to mammalian infections, as well as promote the discovery of 
mechanisms used for metabolism in Chlamydia. 
In summary, this development of a novel transposon system that is functional in 
Chlamydia is a major leap-forward and a valued addition to the growing repertoire of genetic 
manipulations in this field. It is expected to have profound impact on the discovery of biologic 
and pathogenesis related genes, enabling association of single gene insertion with evaluated 
phenotypes. The study has highlighted the current inefficiency in transformation in Chlamydia, 
which will need to be overcome for large-scale mutagenesis studies. Despite this shortcoming, 
there is much promise for this technique and its associated applications, as evident from the 
support for the chlamydial MACPF (CT153/TC0431) in establishment of mammalian infections 
using both the vaginal and transcervical infection models for Chlamydia. There are also high 
expectations that this system will be applicable and functional for studies in other Chlamydia 
species and serovars (e.g. C. trachomatis serovar D), thus enabling animal studies and analysis of 












Genetic Disruption of the Hypothetical Protein CT339 Reveals an Essential 




Chlamydia species are the causative agent for a number of globally relevant diseases 
including blinding trachoma and pelvic inflammatory disease. In spite of a reduced genome, 
variable host and tissue-tropisms are observed between species. Sequence analysis has revealed 
that lateral gene transfer played a critical role in evolutionarily shaping these genomes and 
altering virulence between species. Despite this important biological process, the components 
responsible for lateral gene transfer and DNA uptake in Chlamydia are virtually unknown. The 
development of a novel transposon mutagenesis system for use in Chlamydia resulted in a 
transposon insertion in the C-terminal half of CT339. This gene encodes a protein displaying 
structural similarity to the DNA-uptake protein ComEC, in spite of having limited sequence 
similarity. This Tn disruption rendered the mutant incapable of DNA acquisition when grown in 
cell culture, supporting a role in DNA uptake in Chlamydia. These studies describe the structural 
homology of the hypothetical protein CT339 to ComEC and support a functional role for CT339 









In spite of a single chromosome and relatively small genomes compared to eukaryotic 
organisms, bacteria exhibit extensive amounts of genetic variation; both among and within 
species. Whereas rapid generation times may result in higher probabilities of mutations leading 
to modification or inactivation of genes, these do not account for the acquisition of large 
genomic islands and antibiotic resistance genes observed in a number of bacteria including 
Gram-positives such as Bacillus, Gram-negatives like Helicobacter and Salmonella, and even 
atypical bacteria such as Mycoplasma (Ochman, Lawrence et al. 2000). Similarly, it has been 
hypothesized that without exogenous genetic procurement, irreversibly deleterious mutations 
will accumulate to the point a population becomes extinct, more commonly known as Muller’s 
ratchet (Koonin, Makarova et al. 2001, Koonin 2016). The only mechanisms for avoiding this 
evolutionary annihilation is the ability to obtain genes with redundant functions to those 
deleteriously mutated either through attaining a functional copy of the same gene or new gene(s) 
resulting in a similar outcome, albeit potentially through a modified pathway. Further, the ability 
of an organism to gain new genes leading to entirely novel functions such as the ability to 
metabolize a new carbon source or eliminate a common antibiotic results in increased fitness and 
may promote selectivity and conservation of these genes throughout evolution of the organism 
(Koonin 2016).  
Horizontal (lateral) gene transfer, the movement of genetic material by means other than 
parent to offspring (vertical), has been identified in nearly every bacterial species, particularly 
due to the abundant methods available for transfer into bacterial species. Transposons, Plasmid 
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uptake via conjugation, bacteriophage and molecular parasites are all classified as major 
components of the “mobilome”—any type of movable DNA (Siefert 2009). Through each of 
these mechanisms, the transfer of genes from distantly related bacteria shapes not only the 
genomes of these bacteria, but phenotypically alters the individual strains upon which the genetic 
elements have been acquired. For example, enteropathogenic and enterohemorrhagic strains of E. 
coli have diverged from commensal E. coli due to the acquisition of regulatory and virulence 
proteins via HGT (Mellies, Barron et al. 2007). Likewise, the horizontal acquisition of over 10 
pathogenicity islands within Salmonella contribute to the virulence of the organism with many 
serotype-specific islands contributing to the differential infectivity observed between serotypes: 
the principal example of this is observed between Salmonella Typhimurium and Salmonella 
Typhi in which the horizontally acquired pathogenicity island 7 in S. Typhi promotes systemic 
infections, whereas the absence of this island in S. Typhimurium limits the pathogen to 
gastrointestinal disease (Nair, Alokam et al. 2004). 
The mechanisms for which horizontal gene transfer via transformation are highly 
described for both Gram-positive and Gram-negative bacteria, with few mechanistic gaps 
remaining. For both, exogenous DNA is guided to the cell membrane by a pilus where it is 
degraded into single-stranded DNA (ssDNA) by a DNA receptor coupled with nucleases or 
DNA separating proteins. This ssDNA is then internalized into the cytoplasm through the 
transmembrane pore, ComEC, where it incorporates into the bacterial genome through 
homologous recombination (Johnston, Martin et al. 2014). This incorporation is often 
identifiable by flanking repeat sequences, changes in GC content within segments as compared 
to the remainder of the genome, and the presence of partial operons from distant bacterial species 
(Zaneveld, Nemergut et al. 2008). 
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Among the global pathogen Chlamydia, it has been observed that lateral gene transfer 
played a critical role in shaping the genomes and altering virulence between species. This 
fundamental mechanism drives diversity of the immunodominant major outer membrane protein 
(OmpA) as well as polymorphic membrane proteins (Pmps), antibiotic resistance genes and other 
loci essential for infectivity and development (Gomes, Bruno et al. 2004). Moreover, lateral gene 
transfer occurs readily between strains, often resulting in enhanced tissue tropism and fitness 
against host defenses (Demars, Weinfurter et al. 2007, DeMars and Weinfurter 2008, Jeffrey, 
Suchland et al. 2010, Jeffrey, Suchland et al. 2013). Despite this importance, the components that 
participate in the process for lateral gene transfer and DNA uptake are virtually unknown. 
Similarly, many aspects of C. trachomatis pathogenesis are poorly understood. This is largely 
due to the limitation of few genetic tools that have been available for Chlamydia and the inability 
to experimentally demonstrate the importance of specific gene products to biological and 
infectious processes.  
 The development of a novel transposon mutagenesis system for use in Chlamydia led to 
the ability to directly linking single genes products to phenotypic alterations through random 
genetic disruptions. One of these disruptions, an insertion into the C-terminal half of CT339, led 
to the investigation of the protein product and its functional roles in chlamydial biology. It was 
observed that this protein contains homology to an inner membrane DNA uptake protein, 
ComEC from Gram-positive bacteria and subsequent follow-up experiments confirmed the 
disruption led to the loss of lateral gene transfer between strains. These studies describe the first 
experimental evidence of a component essential for natural competence and DNA uptake 




Methods and Materials 
 
Chlamydial strains and propagation. C. trachomatis serovar L2 434/Bu were propagated as 
described above. Briefly, L929 mouse fibroblast cells (ATCC CCL-1) were grown to confluency 
using RPMI medium 1640 supplemented with 5% Heat-inactivated FBS plus 10µg/mL 
gentamycin (Fisher Scientific, Pittsburg PA) and infected with purified EBs of either WT or Tn 
mutant CT339::Tn (generation method described in chapter 3). Cultures were allowed to grow 
for up to 48 hours at 37°C, 5% CO2. Percent infectivity was assayed by IFA microscopy and EBs 
were harvested as previously described (Mukhopadhyay, Clark et al. 2004) using a series of 
centrifugation and sonication steps to disrupt the host-cells and release EBs. Once isolated, EBs 
were either frozen immediately or further purified using Omnipaque™ (Barrington, IL) and 
ultracentrifugation. All EBs were stored in sucrose phosphate glutamate (SPG) media at -80°C. 
Clonal isolates were obtained as previously described (Suchland, Bourillon et al. 2005).  
 
Bioinformatic analysis of CT339. BLAST analysis and subsequent query within the Conserved 
Domain Database (Marchler-Bauer, Derbyshire et al. 2015) resulted in hits within the 
competence superfamily and multidomain hits for ComEC. Multiple sequence alignments were 
generated using ClustalW and 10 variable species hits within the Clusters of Orthologous Groups 
of proteins (COG0658) (Tatusov, Galperin et al. 2000). The following proteins were used; NCBI 
accession numbers shown in parenthesis: competence protein ComEC family protein Shigella 
dysenteriae 1617 (YP008850592.1), competence locus E Helicobacter pylori Hp P-26 
(EJC51989.1); competence protein ComEC Enterococcus faecium DO (YP006375852.1); ComE 
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Synechocystis sp. PCC 6803 (BAA17126.1); comEC Listeria monocytogenes EGD-e 
(CAC99560.1); ComE operon protein 3 Bacillus subtilis subsp. subtilis str. 168 (NP 390435.1); 
hypothetical protein AGR C 2573 Agrobacterium tumefaciens str. C58 (NP354400.1); 
competence protein Neisseria meningitidis MC58 (NP273744.1); hypothetical protein CT339 
Chlamydia trachomatis D/UW-3/CX (NP 219846.1); ComEC/Rec2 family protein Clostridium 
botulinum A str. ATCC 3502 (YP 001255462.1); ComEA Neisseria meningitidis (CAB44958); 
ComEA protein Helicobacter bilis (WP_004084273); competence ComEA Shigella dysenteriae 
1617 (EFP70107); competence protein ComGA Enterococcus faecium (WP_002304768); 
competence protein ComGA Listeria monocytogenes (WP_009933475); ComGA Bacillus 
subtilis (BAA12533); Multispecies competence protein ComGB (WP_002286180); 
Multispecies: competence protein ComGB Bacilli (WP_048681721); competence protein 
ComGB Listeria monocytogenes (WP_010990101). Multispecies: type IV pilus secretin PilQ 
Neisseria (WP_016686778); Type 4 pili secretin pilQ (outer membrane porin) Shigella 
dysenteriae 1617 (AHA67697); Multispecies: pilus assembly protein PilE Neisseria 
(WP_002214937); ComGC Bacillus subtilis (BAA12535). Five different hydropathy prediction 
programs were used to predict topology for CT339: HMMTOP v2.0 (Tusnady and Simon 2001); 
MEMSAT-SVM (Buchan, Ward et al. 2010); TMHMM2.0 (Krogh, Larsson et al. 2001); 
TOPPRED (Claros and von Heijne 1994); SPLIT (Juretic, Zoranic et al. 2002). Transmembrane 
illustrations were generated and modified using Protter v1.0 (Omasits, Ahrens et al. 2013).  
 
Generation of recombinant clones for assessment of bacterial competence. All experiments with 
tetracycline-resistant Chlamydia described in this work were reviewed and approved by the 
National Institutes of Health Recombinant DNA Advisory Committee (University of 
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Washington). Recombination experiments were performed as previously described (Suchland, 
Sandoz et al. 2009). Briefly, sets of individual shell vials were seeded with McCoy cells and 
subsequently co-infected with combinations of drug-resistant strains: C. trachomatis L1/tetR 
(NCBI accession number ACUI01000000), C. suis R19/tetR, C. trachomatis serovar F/tetR, and 
either C. trachomatis IGR::Tn blaR or C. trachomatis CT339::Tn blaR. Cultures were incubated 
for 40 hours post-infection in the absence of antibiotics then detached using -80°C/37°C freeze-
thaw. Recombinants were isolated by infecting 96 new shell vial monolayers with 1 mL freeze-
thaw lysates and treating with both penicillin and tetracycline and passaged until dually resistant 
clones were detected. Recombinant clones were propagated and cloned by limiting dilution and 
subsequently evaluated for identification of serovar-specific OmpA. DNA from each clone was 
harvested and subject to WGS. Recombinant clones were propagated and purified by limiting 
dilution.  
 
Whole Genome sequencing. DNA was extracted from purified EBs using the Qiagen Blood and 
Tissue Kit. Manufacturer’s instructions were used with minor modifications. In brief, purified 
EBs were aliquoted with Buffer ATL and boiled for 10 minutes at 96°C. Proteinase K was added 
and the reactions were incubated at 56°C for 1 hour. After incubation, Buffer AL and ethanol 
(96-100%) was added and mixed thoroughly by vortexing. The reactions were added onto a 
provided DNeasy Mini spin column and collection tube, and centrifuged at 6000 x g. Two wash 
steps were then performed using Buffer AW1 and AW2 each with centrifugation. Finally, 
reactions were incubated for with Buffer AE for 20mins at room temperature, centrifuged and 
eluate was saved. For quality control, each sample was verified using a spectrophotometer 
(Denovix Ds-11 FX+) to quantify DNA. Extracted DNA was prepared for sequencing at the 
	  121	  
Genome Sequencing Core at the University of Kansas where library preparation and further 
quality control was completed. Samples were multiplexed and run on the Illumina Miseq PE100. 
Paired end reads were generated with a Phred score (>Q30) of 95.44%. Reads were then de-
multiplexed and analyzed on the Geneious software suite. Total read coverage was calculated as 
a function of the proportion of reads that mapped to the WT reference genome (the total of 
chlamydial reads) over the total number of reads generated for the sample, including host and 
other contaminant DNA. A threshold of 10 reads was created to check for the depth of coverage 
at each base pair (2013).   
 
Assembly and Analysis of the Recombinant Progeny. Each recombinant genome was generated 
using reference-guided assembly to the OmpA parental genome. Genomes were then aligned to 
both parental genomes and scanned for regions of homology using the Geneious global 
alignment tool with free end gaps and a cost matrix of 65% similarity. Initial sequence assembly 
was verified through reference-guided assembly to the minority parent. Regions of homology 
were annotated and margins were estimated based on similarity to the individual parents. 
 
Identification of parental backbone and recombination sites. DNA from each clone was 
harvested and subject to PCR using primers for arbitrary regions representative of the whole 
genome (Table 4.1). Amplicons were sequenced using ACGT (Wheeling, IL) for identification 





Table 4.1: Primers used to determine parental backbone of R19/L2 recombinants 
L2xR19 Recombination PCR (5’-3’) 




C. trachomatis ompA GAGCTAAACTTGCTTGCCATTC 751  
CCTGCTGAACCAAGCCTTAT 
C. suis R19 ompA CTAGCACAGGGAATACCACATC 619  
AAGCTTGCTCGAGACCATTTA 
C. trachomatis oppF TGCCTCCAGATGCTCAAGACTC 330  
TTGCCAAATCATCTGCACCGC 
C. suis MD56 oppF ACATCATGGGAGGACTCTCTAA 597  
GCGAAAGTAAATGACGGAATAGC 
C. trachomatis glgB TGATGGAGTACCTGGAGTAAGA 825  
GAGACAGCATCCACACGAATA 
C. suis MD56 glgB CTAGGAGAGCCTTTCGCATTTA 763  
TTGATTTAGCCTCGGTCTTCTC 
C. trachomatis CTL0600 TGGAGACCATTGCTTAGGTTTAG 473  
CTTGTTCCGCAGCTTGTTTG 
C. suis MD56 CTL0600 ACGATTCTAGGCTGTTCAAGTC 592  
GATGGGCGTGCTCTTCTAAA 
C. trachomatis CTL0592 TCTAAACGCACGTTATACGAAGG 200  
TTTCCTTATCGTTATTTGGCTCAAG 
C. suis MD56 CTL0592 CACACCGTACTGAGCATAAA 275  
ATGGTGTACAGTTATAAAGGCT 
C. trachomatis CTL0594 CGCAGCATTGGAAGGATAGA 381  
GTGAGGATGTCGCAGGAAATA 
C. suis MD56 CTL0594 CACAAGCTCACTGCCAAATC 332  
CTGTGGTATTCCTGGAGCATAA 
C. trachomatis CTL0808 TGTAGGAGCGAAATCGAAAGG 560  
GGAAGTCACGAAGGAGCTATG 
C. suis MD56 CTL0808 CTGAGGCGGCAATAGAAACT 441  
ACACTGCTTCTTGGACATACTC 
C. trachomatis CTL0542 AGTTCGAGTTGGATCCGGTAGTTC 149  
AGCAATTCCCTCTCCGATACCTG 





In silico analyses of CT339 support functional prediction as DNA uptake protein ComEC.  
 Given the importance of lateral gene transfer in the evolution and adaptation of 
Chlamydia and the paucity of identifiable gene candidates that may play a role in this 
fundamental process, the Tn insertion in CT339 was of particular interest. CT339 shares limited 
sequence similarity to any single protein outside of Chlamydia; however, it contains similarity to 
multiple competence-associated protein families and conserved domains, including ComEC (E-
values ranging from 2.33e-03 to 4.40e-24). In both Gram-negative and positive bacteria, ComEC 
plays a key role in transporting ssDNA into the cytosol of the bacterial cell during natural DNA 
acquisition (Berge, Moscoso et al. 2002, Draskovic and Dubnau 2005). To further investigate the 
possibility of CT339 encoding a ComEC homolog, in silico analyses were performed. 
Using the Conserved Domain Database, 10 randomly selected proteins from COG658 
with an E-value less than 6E-3 were used to demonstrate the diversity of organisms containing 
the competence motif identified within ComEC, including CT339 from C. trachomatis. These 
integral membrane proteins typically have 9-12 transmembrane helices and a conserved metal-
binding motif HΦxxΦSGΦH (Φ indicate hydrophobic residues, Figure 4.1).  
Topology modeling of CT339 using five hydropathy programs resulted in a range of 8 
(SPLIT) to 11 (MEMSAT) predicted transmembrane segments, similar to the proposed 9-12 
transmembrane regions of ComEC from Bacillus (Draskovic and Dubnau 2005). As previously 
described for ComEC, HMMTOP prediction identified a large N-terminal loop within CT339 






Figure 4.1. CT339 shows sequence similarity competence homology to ComEC. Multiple 
sequence alignment of 10 competence proteins identified as containing the multi-domain 
ComEC from the Conserved Domain Database. COG0658 was used to identify 10 bacterial 
species with similar competence domains and an E-value <6e-3. Hashtags indicate conserved 
histidine metal-binding motifs. Conserved hydrophobic residues are highlighted in cyan.  
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well as the competence domain containing the conserved metal-binding motif HΦxxΦSGΦH 
(Figure 4.2A and B). For all five hydropathy programs, an extracellular N-terminal domain and 
intracellular C-terminal domain were predicted, similar to that of ComEC (Draskovic and 
Dubnau 2005). Contrary to the predicted topology of ComEC, none of the predictive 
transmembrane helices for CT339 display an amphipathic character nor are any segments 
predicted to be buried parallel to the membrane surface (Figure 4.2A). Based on this in silico 
data, a transmembrane topology model was designed (Figure 4.2B) supporting the structural 
homology between CT339 and ComEC, specifically within conserved competence domains and 
the N-terminal loop. Further experimental analysis suggests CT339 may be functioning similar 
to ComEC as a component of bacterial competence and may lead to identification of a 
mechanism for DNA uptake among similar obligate intracellular pathogens. 
 
Requirement of CT339 for DNA uptake via lateral gene transfer.  
 Chlamydia has been demonstrated to be naturally competent, acquiring and integrating 
DNA within or between certain Chlamydia species (Suchland, Sandoz et al. 2009). Importantly, 
the mechanisms and components for this process are poorly understood. The transposon insertion 
in CT339 provided an opportunity to experimentally evaluate the importance of this gene 
product in DNA uptake and support the prediction of CT339 as a functional homolog to ComEC. 
Lateral gene transfer during co-infections, including the transfer of specific antibiotic resistance 
genes, has been demonstrated to occur between C. trachomatis strains (intra-species) as well as 
between C. suis and C. trachomatis (inter-species) (Suchland, Sandoz et al. 2009). To evaluate 
the importance of CT339 in lateral gene transfer, intra-species co-infections followed by dual 







ComE operon protein 3 Bacillus subtilis subsp. subtilis str. 168 G V V H L L A I S G L H 
 ComEC Listeria monocytogenes EGD-e G V V H L L A I S G L H 
 Competence protein ComEC Enterococcus faecium DO G L L H L F S L S G L H 
 ComEC/Rec2 family protein Clostridium botulinum A str. ATCC 3502 G V I H A V S V S G F H 
 ComE Synechocystis sp. PCC 6803 G L S H F L A A S G Y Q 
 Competence locus E Helicobacter pylori Hp P-26 G I N H L L A I S G F H 
 Hypothetical protein AGR C 2573 Agrobacterium tumefaciens str. C58 G L A H I V A I S G L N 
 Competence protein ComEC family protein Shigella dysenteriae 1617 G T A H L M A I S G L H 
 Competence protein Neisseria meningitidis MC58 G L T H L V S I S G L H 
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Figure 4.2 CT339 shows structural homology to ComEC. A and B) Hydropathy plots of 
both ComEC from Bacillus subtilis (A) and CT339 from Chlamydia (B). Both predicted 
competence proteins display a large extracellular N-terminal loop stabilized by two cysteines 
(highlighted in yellow) and an extended C-terminal loop. The competence domain as 
identified by the conserved domain database is highlighted in blue.  
	  129	  
strains. Recombination rates and acquisition of antibiotic resistance markers were assessed by 
parental OmpA serotype (e.g. L1 vs. L2). 
Intra-species co-infections and dual antibiotic selection with tetracycline resistant C. 
trachomatis L1 (L1/tetR) and either CT339::TnblaR (339) or the transposon control mutant 
CT383/4::TnblaR (IGR) were performed. When C. trachomatis L1/tetR and IGR were co-
infected, roughly equal amounts of recombinant progeny displaying either parental OmpA (L1 or 
L2) were observed. In contrast, when the same L1/tetR parent was co-infected with 339, nearly 
100-fold lower progeny displaying the L2 OmpA were observed (Table 4.2). While this 
supported the importance of CT339 (comEC) in DNA acquisition, the low levels (~103 IFU of 
L2) might suggest that this gene product is not essential for the process.  
An alternate hypothesis was posed to explain the low level of L2 OmpA positive 
samples: that a region including the L2 ompA gene, in addition to the CT339::TnblaR marker, 
was transferred and integrated into L1 parent organisms containing intact, functional CT339. To 
investigate this hypothesis, whole genome sequencing on several recombinants from each co-
infection (L1/tetR vs L2 CT339::TnblaR or L2 IGR::TnblaR) were performed. As indicated in Fig. 
4.3, L1/tetR and L2 IGR::TnblaR crosses yielded genomes that predominantly reflect the OmpA 
serotype. Specifically, L2 or L1 OmpA positive samples had an average of 84% L2 or 78% L1 
genomic composition, respectfully. In contrast, L2 OmpA positive samples generated after a 
L1/tetR x L2 CT339::TnblaR co-infection had relatively minimal L2 genome in the resulting 
clones, with an average genomic L2 composition of 36% (Fig. 4.3), less than half as much as 
observed in IGR v L1 crosses. Matching the levels of antibiotic resistance transfer in CT339 





Table 4.2. OmpA Phenotype of L1/L2 Tn Recombinant Progeny  
L1/tetR x IGR::Tn blaR 
Cross L1 OmpA IFU L2 OmpA IFU % L2 Progeny 
1 9 x 105 7 x 105 43.8 
2 8 x 105 6  x 105 42.9 
3 9 x 105 6 x 105 40  
L1/tetR x CT339::Tn blaR  
1 5 x 105  7  x 103 1.4 
2 6 x 105  8  x 103  1.3 










































Figure 4.3. Assessment of lateral gene transfer using Tn mutants. Schematic 
representation of recombinant progeny genomes. Blue bars represent the regions of the 
genome from the L1/tet
R
 parent. Gray bars represent regions from either L2 CT383/4::Tn bla
R 
(IGR) or L2 CT339::Tn bla
R
 parent. A) Progeny genomes from crosses between tetracycline 
resistant C. trachomatis L1 and CT383/4::Tn bla
R 
(IGR). B) Progeny genomes from crosses 




composition (Fig. 4.3). These data support the hypothesis that DNA regions containing L2 
OmpA and the CT339::TnblaR marker, was most likely acquired by L1 parent clones.  
The generation of L1/tetR/L2 CT339::TnblaR clones provided an excellent opportunity to 
further investigate the possibility of incomplete CT339 requirement for DNA acquisition and 
genome incorporation. These clones were used in co-infections with the parent L2 
CT339::TnblaR clone with dual antibiotic selection. If CT339 is essential for DNA acquisition 
and incorporation, then all resulting clones should be only L1 OmpA positive. If CT339 is only 
partially required, then it would be expected to observe mixed L1 and L2 OmpA populations (i.e. 
the tetR marker transferred and incorporated into the L2 genome or L2 OmpA transferred and 
incorporated into the L1 genome). Three independent co-infections revealed that only L1 OmpA 
positive inclusion was observed with an extensive amount of IFUs (~5 x 107) per evaluated cross 
(data not shown). Additionally, transformation of the L2 CT339::TnblaR was also attempted 
using an inducible GFP plasmid (pTLR2-GFP), and chloramphenicol for selection. Every 
attempt to transform L2 samples that had an intact chromosomal CT339 were successful using 
the inducible plasmid. In contrast, none of the attempts to transform L2 CT339::TnblaR with the 
plasmid were successful (data not shown).  Taken together, these data support the hypothesis that 
CT339 is critical for DNA uptake and is likely serving as a ComEC functional homolog in 
Chlamydia trachomatis.  
To further address the functionality of CT339 in lateral gene transfer, similar co-
infections and dual selection experiments were performed with tetracycline resistant C. 
trachomatis serovar F (F/tetR). Using a more distant species relative reduces the challenge of 
delineating highly similar genomic crossover regions, although this also reduces recombination 
rates. Three independent crosses and selections were performed with C. trachomatis F/tetR and 
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either C. trachomatis L2 IGR::Tn blaR or L2 CT339::Tn blaR. As observed in the L1 x L2 IGR 
experiments (Table 4.2), approximately half of the inclusions exhibited either OmpA F or L2 
seroreactivity (Table 4.3). Similar to the L1/tetR vs L2 CT339::Tn crosses, more than 99.94% of 
the inclusions were positive for only OmpA F (Table 4.3), strongly supporting the reliance of 
CT339 for DNA uptake in C. trachomatis. 
Finally, inter-species co-infections with C. suis R19tetR and C. trachomatis 
CT339::TnblaR or CT383/4 (IGR)::TnblaR were performed. After an initial growth without 
antibiotics, lysates from co-infections were diluted among 96 individual vials in the presence of 
dual antibiotic selection. Infections were passaged until visible inclusions were observed and 
subsequently evaluated for identification of either C. suis or C. trachomatis-specific OmpA. The 
genetic variation of the two Chlamydia species allowed for accurate identification of source 
genome regions that were recombined following lateral gene transfer.  
 For co-infections with C. suis R19tetR and C. trachomatis IGR::TnblaR, an average of 
approximately 15 dual resistant cultures were detected (range 8-23). Of these, the vast majority 
(94% with an average of 14 resistant cultures; range 8-21) of the resulting cultures were positive 
for C. trachomatis OmpA, supporting that lateral transfer of the tet gene from C. suis into C. 
trachomatis genome occurs readily in the control IGR::TnblaR clone (Figure 4.4A). In contrast, 
very few (6% with an average of 1 resistant culture; range 0-2) of these co-infections yielded 
dual resistant cultures that were positive for C. suis OmpA (Figure 4.4A). This suggests that the 
recombination regions surrounding the IGR::TnblaR may be poorly compatible with the C. suis 
genome. When co-infections with C. suis R19tetR and C. trachomatis CT339::TnblaR were 
performed, dual resistant clones that stained positive for C. suis OmpA were more detected 




Table 4.3. OmpA Phenotype of F/L2 Tn Recombinant Progeny  
F/tetR x IGR::Tn blaR  
Cross F OmpA IFU L2 OmpA IFU % L2 Progeny 
1 5 x 105 4 x 105 44.4 
2 5 x 105 3  x 105 37.5 
3 3 x 105 3 x 105 50 
F/tetR x CT339::Tn blaR  
1 1  x 104 4 x 100 0.04 
2 2  x 104 7 x 100 0.04 
3 9  x 103 5 x 100 0.06 
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suis R19tetR genome at this site (CT339::Tn) is more readily accepted. Strikingly, no lysates from 
any of these five co-infection experiments stained positive for C. trachomatis OmpA. This 
observation supports the hypothesis that disruption of CT339 renders the C. trachomatis 
recipient cell incapable of DNA uptake during lateral gene transfer. 
 To provide a more comprehensive analysis of the recipient genome’s species, sequence 
analysis of three loci (glgB, oppF, and Q499_0583/CTL0808/CT546) distributed around the 
genome was performed (Figure 4.4B). For all of the resulting progeny following co-infection 
with C. suis and C. trachomatis, all amplicon sequences matched the species defined by the 
OmpA seroreactivity. While this approach is a relatively crude genome investigation, it does 
support that antibiotic resistant loci (tetR or blaR) from a given donor species is transferred into a 
predominately species-specific genome. While it is highly unlikely that spontaneous mutations 
would occur that rendered Chlamydia cultures resistant to β-lactams or tetracycline, PCR 
sequence analysis of antibiotic resistant genes (bla and tet) of all dual-resistant lysates supported 
their presence and contribution to resistance. To further determine the directionality of antibiotic 
resistance transfer between strains, whole genome sequencing will be performed. Additional 
experiments utilizing recombination with the L1 C. trachomatis serovar are also underway, as 
previous studies have shown C. trachomatis serovars readily exchange genetic material, whereas 
recombination between species (C. trachomatis and C. suis) has resulted in exceedingly low 





Figure 4.4. Recombination with CT339::Tn results in lack of DNA uptake. A) Serotypes 
of parental strains and progeny from 5 independent recombination crosses. Isolates are 
displayed as the percent wells showing growth with respective progeny OmpA stain. B) 
Graphical representation C. suis R19 x CT339::Tn hybrid progeny. Arbitrary genes 
throughout the genome were amplified and sequenced for identification of direction of genetic 
transfer. Red region indicates Tet resistance specific to C. suis. and C. suis Q499_RS00035 
indicated at the top of the representative genomes for reference. Green boxes indicate genes 
sequencing for C. suis MD56 reference strain. Yellow box indicates hypothesized Tn 
recombination region including CT339::TnblaR. Gray shadow indicates region of C. suis 






For nearly all bacteria, the ability to uptake exogenous DNA is essential for genetic 
variability resulting in beneficial evolutions in fitness. Horizontal gene transfer both between and 
within species has resulted in bacteria obtaining new means for survival as well as pathogenicity. 
In the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile, both toxins and 
antibiotic resistance genes appear to have been horizontally acquired, resulting in two of the 
most prevalent hospital-acquired, multi-drug resistant human pathogens (Juhas 2015). Along 
with gaining genes through plasmid and transposon insertion, a new mechanism for genetic 
transfer known as “microbial superhighways” has been identified in which bacteria are shown to 
form nanotubules for transfer of proteins, small molecules and nucleic acids (Dubey and Ben-
Yehuda 2011, Schertzer and Whiteley 2011). These tubules have been shown to occur in 
eukaryotes, both plants and animals, and given the hypothesized ancestral symbiosis between 
Chlamydophila and plant species, it may not be farfetched to believe these tubules may have 
been responsible for early horizontal gene transfer between them (Bordenstein and Reznikoff 
2005). 
Within Chlamydia, there is no evidence of conjugation machinery, only six 
bacteriophages have been identified with none known to infect the globally prevalent C. 
trachomatis (Pawlikowska-Warych, Sliwa-Dominiak et al. 2015), and while there is evolutionary 
evidence for transposon insertion, this is only present in C. suis strains containing a tetracycline 
resistance cassette (Marti, Kim et al. 2017). Thusly, the only explanation for genetic diversity 
among species, including the presence of plant-derived transport proteins, variability among 
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Pmps, and acquisition of eukaryote-only helicases, is the ability for Chlamydia to readily take up 
foreign DNA from the environment. Indeed, both within the laboratory and within nature, 
Chlamydia has been shown to be capable of transformation, although at relatively low levels 
compared to other bacteria (Gomes, Bruno et al. 2004, Demars, Weinfurter et al. 2007, Suchland, 
Sandoz et al. 2009).  
What has remained intangible is how Chlamydia procures foreign DNA. To date, the 
machinery associated with DNA uptake: pilins, porins, nucleases etc., have not been functionally 
annotated within C. trachomatis. Through random mutagenesis using transposons, however, we 
have identified a key component in DNA uptake: the ComEC homolog CT339. 
We have shown in silico that CT339 structurally resembles ComEC as described in 
Bacillus (Draskovic and Dubnau 2005) with multiple transmembrane domains, the competence 
motif and a large N-terminal loop containing potentially stabilizing cysteines (Figure 4.2). Co-
infection experiments using the transposon insertion mutant in CT339 (CT339::Tn) showed an 
observable absence of lateral gene transfer capability, providing compelling support for the 
essential contribution of this gene product to this fundamental evolutionary process. According 
to the protein family database (pfam) architecture, genes encoding proteins containing this 
competence motif are typically encoded near a lactamase-superfamily protein that are predicted 
to regulate the competence operon (Charpentier, Faucher et al. 2008). Genome analysis of C. 
trachomatis identified ribonuclease Z (CT346), a lactamase-superfamily protein, neighboring 
CT339 and suggesting that this protein may be involved in the chlamydial competence system. 
As previously mentioned, other potential components involved in DNA uptake in Chlamydia are 
less evident. Pili or pseudopili predominantly facilitate binding and transport of DNA to the 
bacterial surface, although no proteins sharing any sequence similarity to pili homologs were 
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identified in Chlamydia. Interestingly, Helicobacter pylori is unique among naturally 
transformable bacteria in that it does not use pili but instead relies upon a dedicated type IV 
secretion system for DNA uptake (Hofreuter, Odenbreit et al. 2001). Gram-negative bacteria 
typically transport dsDNA through an outer membrane secretin channel (e.g. PilQ), which is then 
processed into ssDNA with periplasmic protein, ComEA. Single stranded DNA is then 
transported through inner membrane protein ComEC and into the bacterial cytoplasm where it is 
bound by RecA or DprA (Johnston, Martin et al. 2014). Direct pairwise BLAST analysis of C. 
trachomatis with numerous gram-negative secretin homologs (PilQ) revealed sequence similarity 
(E-values <10-9) to only a type II and type III secretion outer membrane proteins, GspD (CT572) 
and YscC (CT674), respectively. Similarly, no protein with similarity to various ComEA or 
DprA homologs was identified through sequence based pair-wise analysis.  
Clearly there is much to be learned about the Chlamydia DNA uptake system although it 
is safe to state that, similar to H. pylori, Chlamydia is likely an exception to the general DNA 
uptake model. Current follow-up studies to further functionally annotate CT339 are ongoing, 
including attempting to transform CT339::Tn, identifying biophysical properties of CT339 such 
as extracellular loops and stabilizing cysteine, as well as more in-depth recombination assays. 
Nonetheless, this study marks not only the first relevant application of transposon mutagenesis to 
assign functionality to a given gene product but also identifies a central component for the 
process of DNA uptake shown to occur in Chlamydia, providing a foundation for explicating the 








Over the past 20 years, reported Chlamydia cases have been steadily increasing, yet few 
advances in prophylactic treatment or antibiotic therapy have become available. This impediment 
is largely due to the scarcity of understanding in terms of basic biology of the organism. With a 
poor comprehension of the functional and biological roles gene products may be playing in 
survival of the bacterium, construction of appropriate pathogen-specific treatments is 
encumbered. Moreover, the obligate intracellular niche in which Chlamydia survive has inhibited 
the ability of basic genetic studies in order to identify these essential components. While there 
are currently no threats of antibiotic resistance in the human-adapted C. trachomatis species, 
evidence of resistant gene acquisition and chronic, persistent infections insinuate forthcoming 
public health complications which, if not anticipated, have the potential for devastating outcomes 
(Suchland, Sandoz et al. 2009, Schoborg 2011). The research presented herein takes a 
foundational approach to biology, developing the tools necessary for understanding these genetic 
correlates of infection. Two different approaches were developed and assessed to encompass the 
gain- and loss-of-function approaches to understanding the roles of both individual genes, and 
integral loci in chlamydial infectivity. One gene product identified using these techniques, 
CT339, was also the subject of successive analysis for functionality in the competence pathway 
of DNA uptake, demonstrating the feasibility of the approach and resulting discoveries that can 
be made upon its utilization.  
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Advantages and disadvantages of homologous recombination as a means for identifying 
genetic correlates. 
 
With a highly reduced genome, it is predicted that chlamydial species have retained only 
those genes essential for growth and pathogenesis. In spite of evolutionary host-speciation of the 
bacteria, remarkably high levels of genetic similarity are retained. Between C. trachomatis and 
the mouse-adapted species C. muridarum, over 98% genome similarity is present, yet upon 
infection of mice, each shows dramatically different phenotypes with regard to pathogenesis 
(Thomson, Holden et al. 2008, Stephens, Myers et al. 2009). What remain unclear are the 
specific genetic variances between these species that account for this disparity.  
The process by which Chlamydia ascend into the UGT has been the topic of debate for 
decades with a general agreement that it is likely multifactorial, involving both the bacterial 
induction of inflammation, fluid movement based on host reproductive cycles, and interactions 
between pathogens and commensal microenvironments (Pal, Hui et al. 1998, Gupta, Wali et al. 
2014). Along the same lines, it is expected that numerous genes and regulatory components are 
involved in Chlamydia establishing mammalian infections. Bearing in mind the high similarity in 
genetic content between C. trachomatis and C. muridarum, the 2% of dissimilarity in genome 
syntony may account for these contrarieties, found within a ~50kb region of the genomes 
adequately named the plasticity zone (Read, Brunham et al. 2000). The immense size of this 
variable region, along with the challenges encountered using historic genetic manipulation 
techniques led to the development of an innovative approach to genome assessment using 
Chlamydia’s natural ability to undergo homologous recombination (Demars, Weinfurter et al. 
2007, Suchland, Sandoz et al. 2009). The major advantage for using recombination is the ability 
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to transfer large genomic clusters using less complicated genetic modification techniques: 
organisms capable of recombination need only selective markers for isolating progeny; the 
remaining tools required are encoded in the bacteria itself. Additionally, while reverse genetic 
approaches are useful in identifying roles of single genes through loss-of-function (Griffiths, 
Miller et al. 2000), these methods are less than ideal for the investigation of proposed multi-
genetic physiognomies, such as the mechanisms behind chlamydial ascension. Independent of 
gene products contributing to ascension, it is anticipated that non-coding regulatory components 
are also having an effect, as has been observed in other intracellular pathogens including 
Brucella and Coxiella (Ahmed, Zheng et al. 2016). Targeted genetic disruption would not detect 
these features and, as such, indispensable genetic constituents may be overlooked.  
The methods by which recombinant clones were generated efficaciously resulted in 
isolation of triple-antibiotic resistant progeny. Two of these resistance markers were of C. 
trachomatis origin, while ofloxacin resistance was conferred from C. muridarum (Figure 2.2). 
Unfortunately, resistance to fluoroquinolones is easily generated through a point mutation in the 
DNA gyrase subunit A (Barnard and Maxwell 2001) and previous work has shown keeping 
chlamydial growth under antibiotic pressures for as little as four passages resulted in increased 
levels of antibiotic resistance (Sandoz and Rockey 2010). This was the only marker for C. 
muridarum among recombinant progeny, thus it was not surprising to find that for nearly half the 
recombinant library, ofloxacin resistance was not the result of C. muridarum gene integration but 
instead spontaneous mutations in C. trachomatis gyrA. Brief analyses and whole genome 
sequencing of one clone confirmed that genomes from spontaneous-mutation ofloxacin-resistant 
isolates were entirely of C. trachomatis origin, showing no recombination with C. muridarum. 
Reflecting on how few passages are necessary to generate this spontaneous mutation, it is 
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expected that multi-pass cultures or samples that underwent extensive clonal dilutions would be 
mainly C. trachomatis. In fact, it was calculated that between the two most recent recombination 
experiments, of ~18 vials kept under selection and serially passaged, 12 isolates sequenced 
positively for C. trachomatis gyrA (data not shown). Future studies in which a less mutable 
target or more than one C. muridarum identifiable marker are incorporated will assist in the 
generation of recombinant clones. Selection of isolates based on C. muridarum reactive IncA, for 
example, would provide a more stable identifier and, as it flanks the right terminus of the 
plasticity zone, may provide a novel locus for assessment of ascension.  
Looking beyond technical insufficiencies that can easily be overcome, more profound 
disadvantages to using homologous recombination require attention. Whole-genome analysis has 
shown Chlamydia has a non-uniform genome, meaning that genes associated with similar 
functions or biological roles may not be in close proximity to each other (Thomson, Holden et al. 
2008). As it is hypothesized that ascension presumptively requires numerous genes and 
regulatory components, it may be that these are not located within the same loci. Supposing this 
is the case, observable gain-of-function phenotypes could be very difficult to obtain. Similarly, 
the regions of C. muridarum that may integrate into C. trachomatis or vice versa are relatively 
unrestricted in size; fragments of C. muridarum can span anywhere between IncA and rpoB 
(Figure 2.2), a nearly 200 kb region. Assuming a gain-of-function mutant is isolated from a 
hybrid spanning this region, the follow-up analysis to determine which precise components are 
responsible for the phenotype is unreasonable. Rather, a second round of recombination utilizing 
this isolate, in which hybrids are generated with more narrow regions of integration, would be 
more feasible. This all results in tedious experimental set ups and maintenance of cocultures, 
while remaining conscious of the spontaneous mutations that may arise with continued 
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propagation. Instead, the generation of parental strains encoding a diverse array of resistance 
markers would be more useful. 
The analysis of the hybrid clones that were generated through the crosses did reveal a 
feature common among the genomes. Practically all isolates encoded trpA from C. trachomatis 
and TC0440 from C. muridarum. As mentioned before, it is perhaps due to the span of 
homologous sequences present within this region, however, it could be due to a potential toxicity 
associated with cytotoxin integration into a C. trachomatis genome. Numerous conversations 
between chlamydiologists have expounded on the difficulties of cloning recombinant cytotoxins 
and disruptions of the cytotoxins have not been done in which all three are activated	  (Newman 
2015). Prior to this work, attempts to recombinatorally modify the cytotoxins have not been 
attempted. It may be that these genes encode redundant functions, therefore phenotypes will not 
be observed with single and double knockouts. Although, seeing as the chlamydial genomes are 
highly reduced, it is likely species would not maintain genes with redundant functions unless 
absolutely necessary and, if absolutely necessary that these gene products be maintained, 
disruptions of one or two should result in distinguishable phenotypes. Therefore, it is improbable 
that the cytotoxins are functioning in the same roles. What remains clear is that downstream 
recombination from TC0440 does not result in ascension detectable seven days post infection 
(Figure 2.7). The variation in organisms observed in cervix tissues may be indicative of bacterial 
clearance and therefore analysis taken at earlier timepoints are necessary. Previous studies using 
transcervical administration of C. trachomatis shows peak of infection between 3 and 7 days 
post-infection (Gondek, Olive et al. 2012, Fischer, Harrison et al. 2017) therefore future analysis 
in which organs are harvested at roughly 5 dpi should be implemented.  
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In order to identify the numerous genetic correlates associated with Chlamydial 
ascension, homologous recombination offers advantages over all other molecular genetic 
approaches: the ability for integration of large genomic regions and relatively simple methods 
obtaining hybrids. These genetic regions have the potential to incorporate both genes and 
regulatory sequences essential for novel functions. While considerations should be made 
regarding the technical aspects of obtaining recombinants, the generation of more diverse 
selection markers placed uniformly throughout the genome will provide more opportunities for 
targeted recombination incorporating specific loci of interest.  
 
Transformation efficiency is a limiting factor for library generation. 
 
 Transposon mutagenesis has been paramount in terms of generating mutant libraries and 
identifying genes essential for growth and survival in a number of organisms. These include: 
Neisseria (Mendum, Newcombe et al. 2011), Streptococcus (Le Breton, Belew et al. 2015), and 
Mycobacterium (Griffin, Gawronski et al. 2011, Long, DeJesus et al. 2015), with up to 30% of 
genes screened determined to be essential for bacterial fitness.  For Chlamydia, this is the first 
report of a functional Tn mutagenesis system and therefore the initial generation of libraries for 
the assessment of gene essentiality.  It is expected that a saturation point will be achieved, in 
which recurrent insertions within repeated genes will be observed, and all genes capable of 
sustaining mutations will have been identified. To expedite the process, using a derivation of the 
formula for Poisson’s Law (Zilsel, Ma et al. 1992), the number of Tn mutations required to 
disrupt every gene within the genome can be theorized. The formula for which is as follows:  
𝑁 =
ln	  (1 − ∅)
ln(1 − 𝑓)  
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in which ∅ is the probability of hitting a particular gene of interest, 𝑓 is the average size of each 
gene within the genome and 𝑁 is the  number of mutant isolates required to hit said 
probability	  (∅). Chlamydia contains a ~1Mb genome with ~900 coding sequences, resulting in 
an average gene size of ~1000 bp (Stephens, Kalman et al. 1998, Nunes, Borrego et al. 2013), 
giving an 𝑓 value of 1/1000 or 0.001. Naturally, not every gene will tolerate an insertion; 
disruption of those absolutely essential for growth and survival such as DNA replication, 
translation, and other critical cellular processes would result in an inability for Chlamydia to 
survive in cell culture and thus, no growth would be observed. Previous work from Bastidas et. 
al showed C. trachomatis L2 is capable of withstanding at least 99 nonsense mutations within 84 
open reading frames (Bastidas and Valdivia 2016). In order to attain similar numbers of mutants, 
using the aforementioned formula, nearly 105 successful transformations must be accomplished 
e.g. 10%	  of	  the	  genome = 56	  (789.7)
56(789.997)
.  
As described in chapter 3, one transformation split into 12-wells resulted in between 4-6 
wells showing successful transformants and growth of Tn mutants. It would therefore take 
between 17-26 transformation experiments (i.e. 12-well plates) to meet the same 10% genome 
mutation reported by Bastidas (Bastidas and Valdivia 2016). Given that disruptions in essential 
genes will result in lack of bacterial growth entirely, attempting to mutate every gene in the 
genome, such that ∅ = 0.99, will provide the theoretical opportunity to hit every gene and 
identify all genes capable of sustaining an insertion. To achieve this, however, nearly 5000 
successful transformation experiments are required, or over 1000, 12-well plates 
(99%	  of	  the	  genome = 56	  (789.==)
56(789.997)
).  
Given the sheer workload associated with these protocols— 4 rounds of serial passages 
onto new monolayers every 36 hours— the numbers of concurrently running experiments 
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becomes an additional limitation for expansion of the library. The typical workflow for mutant 
isolation takes ~1 week and if, for instance, the maximum number of 12-well plates that can be 
maintained at any given time is 5, over 200 weeks’ worth of labor is required. While this may 
vary between individuals, it is clear the remarkably low transformation efficiency is the 
bottleneck for library generation and a ‘brute-force’ approach for obtaining mutants is less than 
ideal.  
To overcome this challenge, a number of approaches may be implemented. The addition 
of a fluorescent marker such as GFP within the C. muridarum library allows for potential sorting 
of transformed bacteria via FACS. Early separation of Tn mutants allows for less serial 
passaging and elimination of competition between potential “slow growers” and those mutants 
that grow similar to WT—allowing for isolation of more dramatically altered phenotypes that 
may have been outcompeted and lost during standard practices. Similarly, using an inducible 
plasmid to turn expression of the transposase on and off may allow for generation of higher 
numbers of mutants. One undesirable outcome of this approach, however, may be the presence 
of multiple insertions; precise control of transposase expression and/or removal of the plasmid 
containing the transposase then becomes crucial. Re-introducing only the transposase on an 
inducible plasmid to an aliquot of an already isolated Tn mutant may also overcome this 
challenge. Within the C. trachomatis library described in chapter 3, it has been confirmed only 
one copy of the blaR gene is present. With only one copy, unrestrained transposase expression 
would simply result in the “jumping” of blaR from one location into another rather than the 
presence of multiple insertions. In using this method, multiple unique, single insertions may be 
isolated, simply by controlling the expression of the transposase. Regardless of method 
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implemented, it is imperative for library generation and subsequent studies that the 
transformation efficiency be improved dramatically. 
   
Transposon mutant CT696 is highly specific to chlamydial biology. 
 
As previously mentioned, the development of a functional Himar1 transposon system 
provided the field with the ability to generate libraries of random, single-gene disruption mutants 
for associated phenotype-genotype correlations. Libraries in both C. trachomatis and C. 
muridarum not only expanded the repertoire of available mutants for functional analyses; it also 
provided the ability to identify differential roles genes may be playing in species-specific 
phenotypes. For example, both libraries contain insertions within the MAC/Perforin from the PZ, 
which, as described extensively above, marks the region of highest genetic diversity. Differential 
functions or expression profiles based on speciation could provide valuable information on roles 
neighboring genes may have in chlamydial biology. Wherein this research describes the 
progressive, broad applications this system offers, it is not without it’s shortcomings. 
Transformation efficiency remains a bottleneck for expanding the library and current protocols 
enrich for disruptions in genes nonessential for growth in cell cultures. Disruptions that show 
dispensability for in vivo infections as well provide little contribution in understanding 
chlamydial pathogenesis. Instead, emphasis should be placed on poorly-characterized gene 
products such as the disruption observed in CT696::Tn. With no sequence homology to proteins 
outside Chlamydia and no discernable conserved domains or motifs, it is clear this protein is 
specific to this pathogen and may identify a novel therapeutic target or biological process. 
Unfortunately, the severe defect in development complicates subsequent studies in that stocks of 
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culture are difficult to obtain. Nonetheless, it is clear that inclusion morphology is severely 
impaired in this mutant, suggesting CT696 may be playing a role in modifying the endocytic 
vacuole or maintaining the inclusion upon entry. Four different protein predictors were unable to 
identify worthwhile features within CT696, including ProSite, InterPro or Pfam and seven 
different topology predictors failed to identify signal peptides or transmembrane regions 
(TOPCONS, OCTOPUS, Philius, PolyPhobius, SCAMPI, SPOCTOPUS and PDB-homology). 
Similarly, three different effector protein prediction programs found no evidence that CT696 
may be a secreted effector protein, highlighting the specificity it must have to an obscure aspect 
in chlamydial biology. 
 
Transposon mutants overcome deficiencies observed in recombination techniques. 
 
One unexpected benefit the transposon libraries provided was the ability to overcome 
aforementioned deficiencies in homologous recombination. Currently, the primary 
disadvantage to recombination is the lack of selectable markers throughout the chlamydial 
genomes. Ofloxacin, tetracycline, and rifampicin resistance were the only isolates available 
for use. As shown in Figures 3.3 and 3.4, sites of Tn insertion occur all across the genome, 
providing new regions for directed recombination. Current work generating 
Tn/recombination mutants is underway to assess whether more localized pressures using β-
lactamase can drive integration of all three	  cytotoxins into a C. trachomatis backbone, 
without the concern of spontaneous generation of antibiotic resistance. Analogously, 
isolation of C. muridarum hybrids in which all three cytotoxins have been lost may answer 
the posing question of redundancy, toxicity, and essentiality for survival and infectivity.  	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Identifying how CT339 enables DNA uptake. 
 
Recently, strong experimental evidence supports that CT339 is functioning similar to 
ComEC from Bacillus but how this protein fulfills this function remains poorly understood. 
Computational analysis on Bacillus ComEC proposes that this protein forms a homodimer and 
both disulfide bonds and the intramembrane competence motif maintain this structure (Draskovic 
and Dubnau 2005). The prediction of an OB superfamily fold, a structural component 
responsible for DNA binding, and a C-terminal β-lactamase super family domain in ComEC 
both provide in silico explanations for how this protein functions in DNA uptake. In telomere 
end-binding proteins, OB folds dimerize to allow for binding of ssDNA	  (Theobald and Schultz 
2003). Two independent studies, nearly ten years apart, conclude that ComEC likely dimerizes in 
a manner similar to these end-binding proteins, in that homology modeling predicted the 
presence of similar OB domains in the N-terminal loop (Baker, Simkovic et al. 2016). This N-
terminal loop was previously predicted to exist extracellularly, which is consistent with a 
proposed role in DNA binding. While HHpred and covariance-assisted modeling was not done 
on CT339 like ComEC (Baker, Simkovic et al. 2016), the presence of a large extracellular N-
terminal loop supports that this, too, is functioning in a manner similar to telomere end-binding 
proteins (Figure 4.2B). If ComEC and CT339 dimerize as predicted, the pore formed by the 
competence motif would result in both N- and C-terminal extracellular loops functioning 
together for DNA uptake. The Tn insertion, then, would disrupt proper folding and subsequent 
loop interactions, inhibiting DNA binding and dramatically reducing the ability for DNA uptake, 
as observed (Draskovic and Dubnau 2005).  Future experiments assessing the stabilizing nature 
of the N-terminal cysteines, the potential of pore-formation by the competence motif, and any 
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interaction of extracellular loops with ssDNA would provide conclusive experimental evidence 
for CT339 as a homolog to ComEC. 
The predicted β-lactamase super family domain within ComEC was similarly identified 
using Pfam and homology modeling predicted a catalytically active zinc-binding pocket within 
this domain, functioning as a nuclease (Baker, Simkovic et al. 2016). As was previously 
described for DNA uptake, the endonucleases such as EndA must first cleave double stranded 
DNA into ssDNA (Johnston, Martin et al. 2014). In Bacillus, the endonuclease responsible for 
this cleavage has yet to be identified; the presence of a nucleating domain on ComEC thus 
accounts for this absent enzyme (Baker, Simkovic et al. 2016). Unfortunately, both Pfam and 
SMART analysis of CT339 did not identify any similar nucleating domains (Schultz, Milpetz et 
al. 1998). Considering the presence of a downstream lactamase-superfamily protein CT346, it is 
not surprising that this domain may be absent from CT339. It could be that gene duplication or 
fragmentation resulted in CT346 becoming independent of CT339 and the lack of uniformity 
across the genome corroborates the ~10 genes between these. CT345, for example, is a 
hypothetical protein within this region showing domain conservation to the ATP-dependent 
DNA ligase, CDC9 superfamily of proteins (accession cl25417). This superfamily has shown to 
play important roles in recombination during DNA joining (Wilkinson, Day et al. 2001). 
Presently, no data existing here support this speculation. However, these observations express 
the feasibility of applying Tn mutagenesis for the discovery of complete, functional complexes; 
such as the entire competence apparatus. Overall, using Tn mutagenesis led to the discovery of 
CT339, pinpointing exploration of the genome to this locus for identification of the remaining 
constituents involved in DNA uptake. Exploration and identification of the remaining 
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competence-associated components will provide more thorough understandings of the 
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